Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSMUSG00000021055.7 | estrogen receptor 2 (beta) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_76196455_76197032 | Esr2 | 19484 | 0.134495 | -0.67 | 2.6e-08 | Click! |
chr12_76164612_76164763 | Esr2 | 3028 | 0.222714 | -0.53 | 3.4e-05 | Click! |
chr12_76195934_76196349 | Esr2 | 18882 | 0.135894 | -0.07 | 6.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 370.39 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr14_14354416_14355184 | 124.90 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr8_84197696_84198961 | 94.16 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr5_112001700_112002600 | 58.87 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr5_137349031_137350198 | 57.95 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr19_45016824_45017769 | 55.86 |
Lzts2 |
leucine zipper, putative tumor suppressor 2 |
799 |
0.44 |
chr3_65658208_65659857 | 52.20 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr2_165884402_165885933 | 51.36 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr9_64793074_64793409 | 49.25 |
Dennd4a |
DENN/MADD domain containing 4A |
18099 |
0.18 |
chr10_127508848_127510720 | 48.65 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr7_17059591_17061170 | 48.22 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr11_5168827_5169640 | 48.00 |
Emid1 |
EMI domain containing 1 |
16976 |
0.16 |
chr1_168287679_168288893 | 47.33 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
chr7_142574309_142575453 | 46.82 |
H19 |
H19, imprinted maternally expressed transcript |
1657 |
0.21 |
chr6_125095392_125097556 | 45.50 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr8_70698268_70700333 | 45.07 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr18_3005171_3005609 | 43.16 |
Gm50072 |
predicted gene, 50072 |
10518 |
0.21 |
chr8_120549369_120550473 | 42.70 |
Mir7687 |
microRNA 7687 |
11225 |
0.1 |
chr2_121036499_121036885 | 42.50 |
Epb42 |
erythrocyte membrane protein band 4.2 |
11 |
0.96 |
chr8_84979246_84980613 | 41.39 |
Junb |
jun B proto-oncogene |
1211 |
0.19 |
chr11_116616197_116616677 | 41.38 |
Rhbdf2 |
rhomboid 5 homolog 2 |
7763 |
0.1 |
chr11_120353462_120354038 | 41.30 |
0610009L18Rik |
RIKEN cDNA 0610009L18 gene |
5072 |
0.09 |
chr11_32296772_32297209 | 41.24 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
362 |
0.77 |
chr5_140647773_140649317 | 40.76 |
Ttyh3 |
tweety family member 3 |
452 |
0.77 |
chr2_174347204_174348264 | 40.61 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr1_191641396_191641769 | 40.50 |
Gm37349 |
predicted gene, 37349 |
43935 |
0.11 |
chrX_51204673_51205680 | 40.45 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr5_115436438_115437458 | 39.55 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr5_139796762_139798525 | 39.29 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
129 |
0.94 |
chr11_97435561_97436362 | 39.23 |
Arhgap23 |
Rho GTPase activating protein 23 |
324 |
0.87 |
chr5_137530580_137532081 | 39.22 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr2_26139656_26141133 | 39.14 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr5_140204146_140204297 | 38.74 |
Gm16120 |
predicted gene 16120 |
3164 |
0.23 |
chr4_132075006_132075723 | 38.27 |
Epb41 |
erythrocyte membrane protein band 4.1 |
43 |
0.91 |
chr7_100500401_100501097 | 38.05 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
2403 |
0.14 |
chr1_86525613_86527056 | 37.82 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr9_61370339_61371660 | 37.74 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr15_82184037_82184673 | 37.56 |
Gm49502 |
predicted gene, 49502 |
1161 |
0.29 |
chr16_95990397_95991380 | 37.55 |
Psmg1 |
proteasome (prosome, macropain) assembly chaperone 1 |
2 |
0.97 |
chr11_30648868_30649937 | 37.45 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr6_97204968_97206158 | 37.35 |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
2 |
0.97 |
chr11_31830043_31830943 | 37.30 |
Gm12107 |
predicted gene 12107 |
2167 |
0.31 |
chr14_8286642_8286923 | 37.28 |
Fam107a |
family with sequence similarity 107, member A |
22995 |
0.16 |
chr5_140439026_140439687 | 37.15 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
586 |
0.63 |
chr2_158305932_158306715 | 37.03 |
Lbp |
lipopolysaccharide binding protein |
170 |
0.92 |
chr2_155604522_155604830 | 36.72 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6536 |
0.08 |
chr8_90907824_90909226 | 36.49 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
89 |
0.52 |
chr15_88875576_88876323 | 36.44 |
Pim3 |
proviral integration site 3 |
11029 |
0.13 |
chr5_109557850_109558797 | 36.43 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr5_91292941_91293393 | 36.37 |
Gm19619 |
predicted gene, 19619 |
9746 |
0.24 |
chr11_102375203_102375512 | 36.33 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
1663 |
0.21 |
chr8_122329580_122330425 | 36.14 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr11_87126714_87127907 | 35.87 |
Trim37 |
tripartite motif-containing 37 |
5 |
0.84 |
chr2_152636359_152637068 | 35.78 |
Rem1 |
rad and gem related GTP binding protein 1 |
3746 |
0.1 |
chr9_103007679_103008651 | 35.22 |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
11 |
0.97 |
chr11_11684707_11686418 | 35.18 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr11_117204633_117204995 | 35.11 |
Septin9 |
septin 9 |
5153 |
0.19 |
chrX_142680720_142682167 | 35.10 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr11_74896307_74898160 | 34.92 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chrY_90771840_90772811 | 34.84 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr2_31464551_31464797 | 34.63 |
Ass1 |
argininosuccinate synthetase 1 |
5533 |
0.2 |
chr8_120295274_120295807 | 34.58 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
67084 |
0.09 |
chr15_86058286_86059442 | 34.54 |
Gramd4 |
GRAM domain containing 4 |
8 |
0.98 |
chr7_16046417_16047443 | 34.53 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
991 |
0.44 |
chr6_124919273_124920636 | 34.23 |
Ptms |
parathymosin |
149 |
0.88 |
chr8_68276160_68277629 | 34.20 |
Sh2d4a |
SH2 domain containing 4A |
327 |
0.89 |
chr16_11423409_11423900 | 34.15 |
Snx29 |
sorting nexin 29 |
2946 |
0.31 |
chrX_94366585_94367598 | 34.15 |
Apoo |
apolipoprotein O |
26 |
0.81 |
chr15_77882572_77883557 | 33.92 |
Txn2 |
thioredoxin 2 |
32636 |
0.11 |
chr11_32283952_32284215 | 33.37 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
272 |
0.83 |
chr17_25127091_25127504 | 33.20 |
Clcn7 |
chloride channel, voltage-sensitive 7 |
6094 |
0.1 |
chr6_52163698_52164573 | 33.08 |
Hoxa2 |
homeobox A2 |
696 |
0.33 |
chr10_127062800_127064205 | 32.98 |
Cdk4 |
cyclin-dependent kinase 4 |
32 |
0.93 |
chr7_126271797_126273090 | 32.72 |
Sbk1 |
SH3-binding kinase 1 |
176 |
0.92 |
chr1_36539232_36539550 | 32.68 |
Gm42417 |
predicted gene, 42417 |
33 |
0.94 |
chr12_101028530_101029714 | 32.50 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr5_146687980_146688258 | 32.34 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
18503 |
0.16 |
chr9_63757305_63758776 | 32.31 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr3_103171228_103172264 | 32.20 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr9_114752784_114753499 | 32.02 |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
21968 |
0.13 |
chr1_85163919_85164982 | 31.69 |
Gm6264 |
predicted gene 6264 |
3587 |
0.13 |
chr17_47909349_47909983 | 31.55 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr13_34344501_34346084 | 31.48 |
Slc22a23 |
solute carrier family 22, member 23 |
110 |
0.97 |
chr11_105125823_105126961 | 31.46 |
Mettl2 |
methyltransferase like 2 |
33 |
0.97 |
chr15_85669900_85671551 | 31.45 |
Lncppara |
long noncoding RNA near Ppara |
17109 |
0.13 |
chr11_19924323_19926342 | 31.42 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr7_28179836_28180482 | 31.33 |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
107 |
0.93 |
chr5_119337927_119338125 | 31.27 |
n-R5s175 |
nuclear encoded rRNA 5S 175 |
40781 |
0.19 |
chr15_83375189_83375572 | 31.19 |
1700001L05Rik |
RIKEN cDNA 1700001L05 gene |
8098 |
0.14 |
chr11_75443808_75444173 | 31.15 |
Serpinf2 |
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
4399 |
0.09 |
chr19_5845343_5846183 | 30.99 |
Frmd8os |
FERM domain containing 8, opposite strand |
140 |
0.66 |
chr11_48873308_48874023 | 30.87 |
Irgm1 |
immunity-related GTPase family M member 1 |
1982 |
0.19 |
chr2_173032812_173033942 | 30.80 |
Gm14453 |
predicted gene 14453 |
1203 |
0.38 |
chr18_65025526_65026378 | 30.74 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
150 |
0.97 |
chr12_79557815_79558259 | 30.72 |
Rad51b |
RAD51 paralog B |
230684 |
0.02 |
chr11_78074361_78074827 | 30.47 |
Mir451b |
microRNA 451b |
1353 |
0.16 |
chr13_37666246_37666836 | 30.43 |
AI463229 |
expressed sequence AI463229 |
1 |
0.96 |
chr10_94931912_94932258 | 30.41 |
Plxnc1 |
plexin C1 |
9428 |
0.21 |
chr2_11425648_11426122 | 30.27 |
Gm13296 |
predicted gene 13296 |
5661 |
0.12 |
chr11_87749523_87749886 | 30.21 |
Mir142hg |
Mir142 host gene (non-protein coding) |
5873 |
0.09 |
chr9_121426081_121426568 | 30.20 |
Trak1 |
trafficking protein, kinesin binding 1 |
10349 |
0.19 |
chr15_102017591_102018334 | 29.94 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr10_62980040_62980767 | 29.91 |
Rufy2 |
RUN and FYVE domain-containing 2 |
110 |
0.93 |
chr9_65826224_65827697 | 29.86 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr4_134760766_134761128 | 29.83 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
7077 |
0.2 |
chr12_80103423_80104027 | 29.79 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
9269 |
0.12 |
chr4_133552955_133553552 | 29.75 |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
123 |
0.92 |
chr6_72097140_72098281 | 29.70 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr3_100488535_100489982 | 29.70 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr5_148740927_148741236 | 29.64 |
2210417A02Rik |
RIKEN cDNA 2210417A02 gene |
759 |
0.59 |
chr6_30146983_30147411 | 29.61 |
Mir182 |
microRNA 182 |
18795 |
0.12 |
chr17_70850487_70852089 | 29.59 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr11_32256536_32256847 | 29.52 |
Nprl3 |
nitrogen permease regulator-like 3 |
278 |
0.84 |
chr7_141364719_141364989 | 29.51 |
B230206H07Rik |
RIKEN cDNA B230206H07 gene |
228 |
0.82 |
chr1_24613351_24614205 | 29.47 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr4_119028258_119028409 | 29.47 |
Gm12862 |
predicted gene 12862 |
27848 |
0.08 |
chr11_97434692_97435371 | 29.45 |
Arhgap23 |
Rho GTPase activating protein 23 |
1254 |
0.42 |
chrX_160426520_160426808 | 29.43 |
Adgrg2 |
adhesion G protein-coupled receptor G2 |
628 |
0.76 |
chr4_144949407_144950626 | 29.12 |
Gm38074 |
predicted gene, 38074 |
8832 |
0.2 |
chr2_69897352_69898558 | 29.06 |
Ubr3 |
ubiquitin protein ligase E3 component n-recognin 3 |
652 |
0.6 |
chr10_77110050_77110376 | 29.02 |
Col18a1 |
collagen, type XVIII, alpha 1 |
3492 |
0.22 |
chrX_169997850_169998483 | 28.89 |
Gm15247 |
predicted gene 15247 |
11227 |
0.14 |
chr4_133557474_133557769 | 28.89 |
Gm23158 |
predicted gene, 23158 |
1328 |
0.26 |
chr4_63236307_63236627 | 28.67 |
Col27a1 |
collagen, type XXVII, alpha 1 |
2181 |
0.28 |
chr11_74837693_74838808 | 28.54 |
Mnt |
max binding protein |
782 |
0.52 |
chr5_125389942_125390330 | 28.44 |
Ubc |
ubiquitin C |
66 |
0.92 |
chr5_124439753_124440600 | 28.38 |
Kmt5a |
lysine methyltransferase 5A |
191 |
0.89 |
chr16_76319178_76320114 | 28.24 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
chr7_99837519_99837978 | 28.18 |
Neu3 |
neuraminidase 3 |
9331 |
0.12 |
chr9_111057150_111057866 | 28.08 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
11 |
0.95 |
chr5_143731658_143732384 | 28.06 |
Usp42 |
ubiquitin specific peptidase 42 |
259 |
0.91 |
chr11_100938783_100940230 | 28.02 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr3_89390311_89391266 | 28.01 |
Gm15417 |
predicted gene 15417 |
1062 |
0.22 |
chr1_189695352_189695549 | 28.00 |
Cenpf |
centromere protein F |
7364 |
0.18 |
chr15_79690079_79691459 | 27.99 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr11_106324879_106325283 | 27.90 |
Cd79b |
CD79B antigen |
10319 |
0.11 |
chr19_7240431_7241403 | 27.89 |
Naa40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
117 |
0.93 |
chr19_61057665_61057910 | 27.83 |
Gm22520 |
predicted gene, 22520 |
44242 |
0.12 |
chr6_90712861_90713488 | 27.83 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
3355 |
0.21 |
chr4_137480764_137481043 | 27.75 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
12100 |
0.13 |
chr11_115898961_115899323 | 27.64 |
Smim5 |
small integral membrane protein 5 |
824 |
0.4 |
chr3_30507827_30509444 | 27.54 |
Mecom |
MDS1 and EVI1 complex locus |
852 |
0.52 |
chr12_111353338_111354089 | 27.48 |
Cdc42bpb |
CDC42 binding protein kinase beta |
23906 |
0.13 |
chr1_86527639_86529135 | 27.47 |
Ptma |
prothymosin alpha |
1580 |
0.31 |
chr8_122317511_122318419 | 27.41 |
Zfpm1 |
zinc finger protein, multitype 1 |
10645 |
0.13 |
chrX_42067696_42069057 | 27.38 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr2_168154178_168154991 | 27.36 |
E130018N17Rik |
RIKEN cDNA E130018N17 gene |
71 |
0.93 |
chr11_45854715_45855015 | 27.36 |
Clint1 |
clathrin interactor 1 |
2901 |
0.21 |
chr19_41482494_41483686 | 27.28 |
Lcor |
ligand dependent nuclear receptor corepressor |
61 |
0.98 |
chr11_75462325_75462847 | 27.11 |
Tlcd2 |
TLC domain containing 2 |
871 |
0.25 |
chr4_154122202_154122744 | 27.08 |
Trp73 |
transformation related protein 73 |
5868 |
0.12 |
chr10_121569006_121569830 | 27.02 |
Tbk1 |
TANK-binding kinase 1 |
937 |
0.48 |
chr7_14525378_14525601 | 26.99 |
Obox4-ps2 |
oocyte specific homeobox 4, pseudogene 2 |
4577 |
0.13 |
chr7_103853072_103853426 | 26.99 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
33 |
0.92 |
chr18_82474598_82476191 | 26.91 |
Mbp |
myelin basic protein |
24 |
0.98 |
chr11_98941353_98942362 | 26.83 |
Rara |
retinoic acid receptor, alpha |
2145 |
0.18 |
chr3_104674273_104674621 | 26.79 |
Gm29560 |
predicted gene 29560 |
4437 |
0.11 |
chr9_46012271_46012911 | 26.77 |
Pafah1b2 |
platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 |
99 |
0.68 |
chr6_72391207_72391516 | 26.75 |
Vamp8 |
vesicle-associated membrane protein 8 |
658 |
0.53 |
chr15_76697423_76698657 | 26.67 |
Gpt |
glutamic pyruvic transaminase, soluble |
22 |
0.93 |
chr10_80819581_80819742 | 26.66 |
Jsrp1 |
junctional sarcoplasmic reticulum protein 1 |
6163 |
0.07 |
chr11_70092126_70092295 | 26.61 |
Asgr2 |
asialoglycoprotein receptor 2 |
434 |
0.69 |
chr7_4739300_4740219 | 26.59 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr9_50856310_50857724 | 26.55 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
38 |
0.97 |
chr18_32543067_32543441 | 26.55 |
Gypc |
glycophorin C |
7836 |
0.2 |
chr15_76199374_76200434 | 26.54 |
Plec |
plectin |
69 |
0.94 |
chr8_122551277_122551909 | 26.52 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
264 |
0.83 |
chr8_123181510_123181661 | 26.46 |
Dpep1 |
dipeptidase 1 |
4657 |
0.08 |
chr10_81627030_81627544 | 26.36 |
Sirt6 |
sirtuin 6 |
30 |
0.93 |
chr12_111442215_111442766 | 26.35 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
21 |
0.96 |
chr2_155604966_155605247 | 26.26 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6106 |
0.08 |
chr2_156296379_156296596 | 25.90 |
Phf20 |
PHD finger protein 20 |
82 |
0.94 |
chr10_80576603_80578409 | 25.88 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr15_98608664_98610204 | 25.81 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr7_132772857_132773208 | 25.81 |
Fam53b |
family with sequence similarity 53, member B |
3884 |
0.24 |
chr1_80408527_80409167 | 25.80 |
Gm6189 |
predicted gene 6189 |
23662 |
0.13 |
chr5_113220320_113221537 | 25.75 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
308 |
0.86 |
chr11_101063294_101064479 | 25.56 |
Naglu |
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) |
6126 |
0.09 |
chr11_75925837_75926169 | 25.52 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
112 |
0.97 |
chr13_47250640_47250987 | 25.49 |
Rnf144b |
ring finger protein 144B |
56988 |
0.11 |
chr8_123980624_123981024 | 25.48 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
2298 |
0.17 |
chr10_80160842_80161483 | 25.47 |
Cirbp |
cold inducible RNA binding protein |
4823 |
0.09 |
chr17_71268038_71268559 | 25.47 |
Emilin2 |
elastin microfibril interfacer 2 |
299 |
0.88 |
chr2_167039436_167039757 | 25.39 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
3899 |
0.11 |
chr7_5060805_5061447 | 25.38 |
Gm45133 |
predicted gene 45133 |
923 |
0.22 |
chr6_57767497_57767835 | 25.23 |
Vopp1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
56974 |
0.07 |
chr7_145043442_145043822 | 25.18 |
Ccnd1 |
cyclin D1 |
103707 |
0.05 |
chr5_21141044_21141247 | 25.10 |
Gm42660 |
predicted gene 42660 |
10069 |
0.13 |
chr10_80963206_80963454 | 25.09 |
Gm3828 |
predicted gene 3828 |
8620 |
0.1 |
chr14_64158929_64159285 | 25.08 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
42793 |
0.11 |
chr5_146691845_146692708 | 25.06 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
14346 |
0.17 |
chr14_14353319_14353777 | 25.03 |
Il3ra |
interleukin 3 receptor, alpha chain |
3927 |
0.13 |
chr5_139388991_139389572 | 24.97 |
Gpr146 |
G protein-coupled receptor 146 |
504 |
0.68 |
chr16_23057965_23058373 | 24.97 |
Kng1 |
kininogen 1 |
81 |
0.92 |
chr8_126497512_126498658 | 24.94 |
Gm6091 |
predicted pseudogene 6091 |
21673 |
0.18 |
chr11_75651168_75652336 | 24.93 |
Myo1c |
myosin IC |
242 |
0.88 |
chr12_80084359_80084746 | 24.93 |
Gm36660 |
predicted gene, 36660 |
3118 |
0.18 |
chr10_127288807_127289691 | 24.88 |
Mbd6 |
methyl-CpG binding domain protein 6 |
231 |
0.7 |
chr7_116286230_116286742 | 24.87 |
Gm44867 |
predicted gene 44867 |
3601 |
0.19 |
chr7_28597227_28598470 | 24.86 |
Pak4 |
p21 (RAC1) activated kinase 4 |
238 |
0.53 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.0 | 32.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
31.9 | 95.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
30.6 | 91.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
28.2 | 56.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
25.9 | 103.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
25.2 | 100.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
22.3 | 66.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
20.6 | 61.9 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
20.6 | 61.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
20.0 | 100.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
19.9 | 59.8 | GO:0002432 | granuloma formation(GO:0002432) |
19.5 | 39.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
19.5 | 39.0 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
19.4 | 77.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
18.9 | 56.8 | GO:0048769 | sarcomerogenesis(GO:0048769) |
18.8 | 56.3 | GO:0036394 | amylase secretion(GO:0036394) |
18.7 | 37.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
18.3 | 18.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
18.2 | 54.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
18.1 | 36.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
17.8 | 53.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
17.8 | 53.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
17.6 | 17.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
17.1 | 51.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
17.1 | 51.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
17.1 | 51.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
17.0 | 33.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
16.6 | 49.8 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
16.5 | 49.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
16.2 | 64.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
16.1 | 48.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
16.0 | 48.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
15.8 | 15.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
15.8 | 47.3 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
15.7 | 47.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
15.7 | 62.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
15.6 | 93.5 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
15.6 | 46.7 | GO:0002086 | diaphragm contraction(GO:0002086) |
15.5 | 46.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
15.3 | 46.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
15.3 | 15.3 | GO:0070384 | Harderian gland development(GO:0070384) |
15.2 | 60.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
15.1 | 45.4 | GO:0015793 | glycerol transport(GO:0015793) |
15.1 | 75.3 | GO:0070836 | caveola assembly(GO:0070836) |
15.0 | 75.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
15.0 | 60.1 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
14.9 | 74.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
14.9 | 44.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
14.8 | 88.5 | GO:0015671 | oxygen transport(GO:0015671) |
14.6 | 14.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
14.1 | 56.5 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
14.1 | 14.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
14.1 | 42.3 | GO:0003166 | bundle of His development(GO:0003166) |
14.1 | 42.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
14.0 | 56.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
14.0 | 41.9 | GO:2001225 | regulation of chloride transport(GO:2001225) |
13.9 | 41.7 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
13.9 | 41.6 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
13.9 | 55.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
13.8 | 41.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
13.8 | 41.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
13.7 | 54.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
13.7 | 54.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
13.7 | 27.3 | GO:0050904 | diapedesis(GO:0050904) |
13.5 | 40.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
13.5 | 54.1 | GO:0008228 | opsonization(GO:0008228) |
13.5 | 175.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
13.4 | 67.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
13.4 | 40.3 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
13.4 | 13.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
13.4 | 53.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
13.3 | 40.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
13.3 | 39.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
13.3 | 26.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
13.2 | 53.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
13.1 | 52.6 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
13.1 | 39.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
13.1 | 65.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
13.1 | 65.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
12.9 | 51.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
12.9 | 12.9 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
12.8 | 25.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
12.8 | 38.5 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
12.8 | 64.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
12.8 | 38.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
12.8 | 25.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
12.8 | 12.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
12.6 | 25.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
12.6 | 37.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
12.4 | 37.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
12.4 | 37.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
12.4 | 296.4 | GO:0048821 | erythrocyte development(GO:0048821) |
12.3 | 49.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
12.3 | 36.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
12.3 | 24.6 | GO:0061511 | centriole elongation(GO:0061511) |
12.2 | 36.5 | GO:0000087 | mitotic M phase(GO:0000087) |
12.2 | 24.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
12.0 | 48.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
11.9 | 47.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
11.9 | 59.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
11.9 | 35.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
11.9 | 59.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
11.8 | 59.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
11.8 | 47.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
11.8 | 35.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
11.8 | 70.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
11.7 | 129.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
11.7 | 11.7 | GO:1902930 | regulation of alcohol biosynthetic process(GO:1902930) |
11.7 | 11.7 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
11.7 | 23.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
11.7 | 35.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
11.7 | 46.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
11.6 | 11.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
11.5 | 23.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
11.5 | 34.5 | GO:0032782 | bile acid secretion(GO:0032782) |
11.5 | 91.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
11.5 | 22.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
11.4 | 34.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
11.4 | 34.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
11.4 | 56.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
11.4 | 45.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
11.3 | 34.0 | GO:0003032 | detection of oxygen(GO:0003032) |
11.3 | 33.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
11.3 | 90.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
11.2 | 33.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
11.2 | 56.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
11.1 | 22.3 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
11.1 | 33.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
11.1 | 44.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
11.1 | 11.1 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
11.1 | 66.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
11.0 | 66.0 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
11.0 | 11.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
11.0 | 55.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
11.0 | 77.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
10.9 | 10.9 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
10.8 | 32.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
10.8 | 249.3 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
10.8 | 10.8 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
10.8 | 43.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
10.6 | 21.2 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
10.6 | 10.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
10.5 | 21.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
10.5 | 31.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
10.5 | 94.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
10.5 | 41.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
10.5 | 41.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
10.4 | 83.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
10.4 | 20.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
10.3 | 51.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
10.3 | 20.5 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
10.2 | 40.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
10.2 | 10.2 | GO:2000589 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
10.1 | 30.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
10.1 | 10.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
10.1 | 30.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
10.1 | 40.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
10.1 | 30.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
10.1 | 30.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
10.0 | 30.1 | GO:0015886 | heme transport(GO:0015886) |
10.0 | 40.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
10.0 | 40.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
10.0 | 30.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
10.0 | 10.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
10.0 | 19.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
9.9 | 29.8 | GO:0036166 | phenotypic switching(GO:0036166) |
9.9 | 39.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
9.9 | 9.9 | GO:0071316 | cellular response to nicotine(GO:0071316) |
9.9 | 19.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
9.9 | 69.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
9.9 | 29.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
9.8 | 29.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
9.8 | 49.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
9.8 | 29.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
9.8 | 88.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
9.8 | 19.6 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
9.8 | 19.6 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
9.8 | 39.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
9.8 | 107.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
9.7 | 9.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
9.7 | 29.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
9.7 | 19.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
9.7 | 29.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
9.7 | 38.9 | GO:0007296 | vitellogenesis(GO:0007296) |
9.7 | 19.4 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
9.7 | 38.7 | GO:0043622 | cortical microtubule organization(GO:0043622) |
9.7 | 19.3 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
9.6 | 38.2 | GO:0006116 | NADH oxidation(GO:0006116) |
9.6 | 47.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
9.5 | 56.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
9.5 | 9.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
9.5 | 85.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
9.4 | 37.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
9.4 | 9.4 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
9.4 | 84.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
9.4 | 18.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
9.4 | 9.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
9.4 | 37.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
9.4 | 56.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
9.4 | 46.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
9.3 | 37.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
9.3 | 83.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
9.3 | 9.3 | GO:0042756 | drinking behavior(GO:0042756) |
9.3 | 27.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
9.2 | 27.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
9.2 | 27.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
9.2 | 18.4 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
9.2 | 27.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
9.2 | 9.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
9.1 | 36.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
9.1 | 18.2 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
9.1 | 27.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
9.1 | 36.4 | GO:0036302 | atrioventricular canal development(GO:0036302) |
9.1 | 36.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
9.1 | 36.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
9.0 | 63.3 | GO:0015825 | L-serine transport(GO:0015825) |
9.0 | 27.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
9.0 | 27.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
9.0 | 54.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
9.0 | 9.0 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
8.9 | 35.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
8.9 | 160.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
8.9 | 53.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
8.9 | 17.8 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
8.9 | 8.9 | GO:0018214 | protein carboxylation(GO:0018214) |
8.9 | 97.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
8.9 | 17.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
8.8 | 35.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
8.8 | 61.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
8.7 | 26.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
8.7 | 34.8 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
8.7 | 34.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
8.7 | 78.3 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
8.7 | 8.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
8.7 | 52.0 | GO:0015871 | choline transport(GO:0015871) |
8.7 | 52.0 | GO:0046060 | dATP metabolic process(GO:0046060) |
8.7 | 26.0 | GO:1902075 | cellular response to salt(GO:1902075) |
8.6 | 95.1 | GO:0042730 | fibrinolysis(GO:0042730) |
8.6 | 8.6 | GO:0002159 | desmosome assembly(GO:0002159) |
8.6 | 25.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
8.6 | 17.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
8.6 | 17.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
8.6 | 34.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
8.6 | 77.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
8.6 | 25.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
8.5 | 34.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
8.5 | 51.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
8.5 | 212.8 | GO:0014823 | response to activity(GO:0014823) |
8.5 | 42.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
8.5 | 33.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
8.5 | 25.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
8.5 | 8.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
8.5 | 16.9 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
8.4 | 8.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
8.4 | 16.8 | GO:0043379 | memory T cell differentiation(GO:0043379) |
8.4 | 8.4 | GO:0010958 | regulation of amino acid import(GO:0010958) |
8.4 | 50.3 | GO:0044351 | macropinocytosis(GO:0044351) |
8.4 | 33.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
8.4 | 16.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
8.4 | 16.7 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
8.4 | 33.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
8.3 | 25.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
8.3 | 8.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
8.3 | 16.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
8.3 | 41.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
8.3 | 8.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
8.3 | 41.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
8.3 | 33.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
8.3 | 8.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
8.3 | 33.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
8.2 | 8.2 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
8.2 | 32.8 | GO:0097581 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
8.2 | 73.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
8.2 | 24.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
8.2 | 81.7 | GO:0034063 | stress granule assembly(GO:0034063) |
8.2 | 24.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
8.1 | 8.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
8.1 | 32.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
8.1 | 24.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
8.1 | 24.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
8.1 | 16.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
8.1 | 24.2 | GO:0032439 | endosome localization(GO:0032439) |
8.0 | 8.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
8.0 | 8.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
8.0 | 56.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
8.0 | 8.0 | GO:0097503 | sialylation(GO:0097503) |
8.0 | 39.9 | GO:0006907 | pinocytosis(GO:0006907) |
8.0 | 23.9 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
8.0 | 23.9 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
7.9 | 7.9 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
7.9 | 15.9 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
7.9 | 31.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
7.9 | 15.8 | GO:1903429 | regulation of cell maturation(GO:1903429) |
7.9 | 23.7 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
7.9 | 7.9 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
7.9 | 7.9 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
7.9 | 31.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
7.9 | 23.6 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
7.9 | 47.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
7.9 | 15.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
7.8 | 23.5 | GO:0008050 | female courtship behavior(GO:0008050) |
7.8 | 54.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
7.8 | 94.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
7.8 | 78.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
7.8 | 54.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
7.8 | 15.6 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
7.8 | 78.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
7.8 | 23.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
7.8 | 38.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
7.8 | 23.3 | GO:0060056 | mammary gland involution(GO:0060056) |
7.7 | 7.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
7.7 | 62.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
7.7 | 38.7 | GO:0018101 | protein citrullination(GO:0018101) |
7.7 | 30.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
7.7 | 38.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
7.7 | 7.7 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
7.6 | 22.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
7.6 | 7.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
7.6 | 7.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
7.6 | 45.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
7.6 | 45.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
7.6 | 15.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
7.5 | 15.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
7.5 | 75.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
7.5 | 7.5 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
7.5 | 60.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
7.5 | 67.7 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
7.5 | 30.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
7.5 | 45.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
7.5 | 52.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
7.5 | 29.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
7.4 | 14.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
7.4 | 81.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
7.4 | 14.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
7.4 | 111.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
7.4 | 7.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
7.4 | 22.1 | GO:0015705 | iodide transport(GO:0015705) |
7.4 | 73.8 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
7.4 | 73.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
7.4 | 7.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
7.3 | 22.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
7.3 | 73.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
7.3 | 29.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
7.3 | 29.2 | GO:0019532 | oxalate transport(GO:0019532) |
7.3 | 7.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
7.3 | 14.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
7.3 | 21.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
7.3 | 43.8 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
7.3 | 51.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
7.3 | 87.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
7.3 | 21.8 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
7.3 | 21.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
7.3 | 29.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
7.3 | 21.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
7.2 | 29.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
7.2 | 43.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
7.2 | 21.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
7.2 | 14.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
7.2 | 21.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
7.2 | 14.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
7.2 | 7.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
7.2 | 100.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
7.2 | 43.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
7.1 | 57.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
7.1 | 14.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
7.1 | 21.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
7.1 | 42.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
7.1 | 7.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
7.1 | 35.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
7.1 | 21.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
7.1 | 7.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
7.1 | 14.2 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
7.1 | 63.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
7.1 | 14.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
7.0 | 14.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
7.0 | 7.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
7.0 | 28.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
7.0 | 42.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
7.0 | 7.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
7.0 | 21.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
7.0 | 28.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
7.0 | 7.0 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
7.0 | 7.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
7.0 | 34.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
7.0 | 41.7 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
6.9 | 27.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
6.9 | 6.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
6.9 | 20.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
6.9 | 13.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
6.9 | 27.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
6.9 | 27.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
6.9 | 20.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
6.9 | 13.7 | GO:0006573 | valine metabolic process(GO:0006573) |
6.9 | 6.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
6.9 | 20.6 | GO:0048102 | autophagic cell death(GO:0048102) |
6.8 | 6.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
6.8 | 20.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
6.8 | 20.5 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
6.8 | 13.6 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
6.8 | 34.1 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
6.8 | 88.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
6.8 | 6.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
6.8 | 13.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
6.8 | 20.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
6.8 | 13.6 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
6.8 | 6.8 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
6.7 | 20.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
6.7 | 20.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
6.7 | 6.7 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
6.7 | 6.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
6.7 | 46.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
6.7 | 60.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
6.7 | 53.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
6.7 | 13.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
6.6 | 26.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
6.6 | 6.6 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
6.6 | 53.0 | GO:0043486 | histone exchange(GO:0043486) |
6.6 | 13.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
6.6 | 65.8 | GO:0018904 | ether metabolic process(GO:0018904) |
6.6 | 13.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
6.6 | 19.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
6.6 | 13.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
6.6 | 19.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
6.5 | 19.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
6.5 | 39.2 | GO:0050779 | RNA destabilization(GO:0050779) |
6.5 | 85.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
6.5 | 19.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
6.5 | 13.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
6.5 | 39.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
6.5 | 6.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
6.5 | 13.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
6.5 | 52.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
6.5 | 32.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
6.5 | 6.5 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
6.5 | 6.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
6.5 | 19.5 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
6.5 | 19.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
6.5 | 13.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
6.5 | 12.9 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
6.4 | 25.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
6.4 | 45.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
6.4 | 19.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
6.4 | 38.5 | GO:0051639 | actin filament network formation(GO:0051639) |
6.4 | 12.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
6.4 | 19.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
6.4 | 6.4 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
6.4 | 127.5 | GO:0006301 | postreplication repair(GO:0006301) |
6.4 | 19.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
6.4 | 6.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
6.4 | 44.6 | GO:0030575 | nuclear body organization(GO:0030575) |
6.3 | 50.7 | GO:0051014 | actin filament severing(GO:0051014) |
6.3 | 25.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
6.3 | 12.6 | GO:0043627 | response to estrogen(GO:0043627) |
6.3 | 12.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
6.3 | 18.9 | GO:0033227 | dsRNA transport(GO:0033227) |
6.3 | 18.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
6.3 | 31.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
6.3 | 25.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
6.3 | 31.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
6.3 | 25.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
6.3 | 50.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
6.3 | 12.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
6.3 | 25.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
6.2 | 6.2 | GO:0007127 | meiosis I(GO:0007127) |
6.2 | 24.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
6.2 | 6.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
6.2 | 31.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
6.2 | 6.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
6.2 | 12.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
6.2 | 31.0 | GO:0097421 | liver regeneration(GO:0097421) |
6.2 | 37.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
6.2 | 18.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
6.2 | 18.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
6.1 | 6.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
6.1 | 18.4 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
6.1 | 43.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
6.1 | 6.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
6.1 | 30.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
6.1 | 61.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
6.1 | 12.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
6.1 | 18.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
6.1 | 18.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
6.1 | 24.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
6.1 | 6.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
6.1 | 24.4 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
6.1 | 6.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
6.1 | 24.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
6.0 | 18.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
6.0 | 12.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
6.0 | 6.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
6.0 | 23.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
6.0 | 6.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
6.0 | 35.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
6.0 | 6.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
5.9 | 17.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
5.9 | 11.9 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
5.9 | 23.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
5.9 | 11.9 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
5.9 | 23.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
5.9 | 11.9 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
5.9 | 5.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
5.9 | 41.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
5.9 | 11.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
5.9 | 5.9 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
5.9 | 5.9 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
5.9 | 5.9 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
5.9 | 11.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
5.9 | 11.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
5.9 | 17.7 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
5.8 | 93.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
5.8 | 46.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
5.8 | 17.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
5.8 | 23.3 | GO:0072553 | terminal button organization(GO:0072553) |
5.8 | 17.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
5.8 | 17.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
5.8 | 23.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
5.8 | 52.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
5.8 | 34.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
5.8 | 11.5 | GO:0051451 | myoblast migration(GO:0051451) |
5.8 | 23.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
5.8 | 5.8 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
5.8 | 57.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
5.7 | 5.7 | GO:0034204 | lipid translocation(GO:0034204) |
5.7 | 79.7 | GO:0035909 | aorta morphogenesis(GO:0035909) |
5.7 | 22.8 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
5.7 | 17.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
5.7 | 5.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
5.7 | 11.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
5.7 | 5.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
5.6 | 16.9 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
5.6 | 11.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
5.6 | 16.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
5.6 | 5.6 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
5.6 | 22.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
5.6 | 11.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
5.6 | 16.7 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
5.6 | 11.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
5.6 | 16.7 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
5.6 | 11.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
5.5 | 11.1 | GO:0042119 | neutrophil activation(GO:0042119) |
5.5 | 38.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
5.5 | 11.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
5.5 | 5.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
5.5 | 11.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
5.5 | 16.5 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
5.5 | 27.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
5.5 | 38.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
5.5 | 126.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
5.5 | 10.9 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
5.5 | 5.5 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
5.4 | 21.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
5.4 | 10.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
5.4 | 59.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
5.4 | 21.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
5.4 | 5.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
5.4 | 5.4 | GO:0070254 | mucus secretion(GO:0070254) |
5.4 | 16.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
5.4 | 10.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
5.4 | 21.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
5.4 | 37.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
5.4 | 32.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
5.4 | 32.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
5.4 | 10.8 | GO:0050955 | thermoception(GO:0050955) |
5.4 | 21.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
5.4 | 64.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
5.4 | 16.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
5.4 | 16.1 | GO:0015744 | succinate transport(GO:0015744) |
5.4 | 5.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
5.4 | 32.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
5.4 | 26.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
5.4 | 5.4 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
5.4 | 10.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
5.3 | 5.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
5.3 | 5.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
5.3 | 10.7 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
5.3 | 42.7 | GO:0043248 | proteasome assembly(GO:0043248) |
5.3 | 16.0 | GO:0009838 | abscission(GO:0009838) |
5.3 | 21.3 | GO:0051031 | tRNA transport(GO:0051031) |
5.3 | 16.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
5.3 | 10.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
5.3 | 5.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
5.3 | 37.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
5.3 | 15.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
5.3 | 21.1 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
5.3 | 26.4 | GO:0001842 | neural fold formation(GO:0001842) |
5.3 | 63.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
5.3 | 5.3 | GO:0010159 | specification of organ position(GO:0010159) |
5.3 | 21.1 | GO:0034695 | response to prostaglandin E(GO:0034695) |
5.3 | 5.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
5.3 | 26.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
5.3 | 10.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
5.2 | 15.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
5.2 | 15.7 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
5.2 | 5.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
5.2 | 5.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
5.2 | 20.9 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
5.2 | 15.6 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
5.2 | 5.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
5.2 | 15.6 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
5.2 | 10.4 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
5.2 | 15.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
5.2 | 25.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
5.2 | 139.7 | GO:0043297 | apical junction assembly(GO:0043297) |
5.2 | 51.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
5.2 | 36.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
5.2 | 20.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
5.2 | 51.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
5.2 | 20.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
5.2 | 5.2 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
5.1 | 30.9 | GO:0016266 | O-glycan processing(GO:0016266) |
5.1 | 15.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
5.1 | 25.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
5.1 | 25.7 | GO:0000237 | leptotene(GO:0000237) |
5.1 | 20.5 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
5.1 | 15.4 | GO:0007525 | somatic muscle development(GO:0007525) |
5.1 | 30.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
5.1 | 10.2 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
5.1 | 76.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
5.1 | 5.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
5.1 | 15.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
5.1 | 35.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
5.1 | 45.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
5.1 | 20.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
5.1 | 15.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
5.1 | 25.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
5.1 | 15.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
5.1 | 5.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
5.1 | 5.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
5.1 | 5.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
5.0 | 5.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
5.0 | 60.5 | GO:0051601 | exocyst localization(GO:0051601) |
5.0 | 45.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
5.0 | 10.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
5.0 | 50.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
5.0 | 10.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
5.0 | 5.0 | GO:0010165 | response to X-ray(GO:0010165) |
5.0 | 35.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
5.0 | 30.1 | GO:0002467 | germinal center formation(GO:0002467) |
5.0 | 20.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
5.0 | 25.0 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
5.0 | 5.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
5.0 | 29.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
5.0 | 5.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
5.0 | 9.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
5.0 | 5.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
5.0 | 29.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
4.9 | 14.8 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
4.9 | 4.9 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
4.9 | 39.6 | GO:0046697 | decidualization(GO:0046697) |
4.9 | 29.7 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
4.9 | 14.8 | GO:0031100 | organ regeneration(GO:0031100) |
4.9 | 24.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
4.9 | 4.9 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
4.9 | 24.6 | GO:0045017 | glycerolipid biosynthetic process(GO:0045017) |
4.9 | 14.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
4.9 | 9.8 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
4.9 | 14.7 | GO:0090148 | membrane fission(GO:0090148) |
4.9 | 4.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
4.9 | 39.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
4.9 | 14.7 | GO:0060613 | fat pad development(GO:0060613) |
4.9 | 29.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
4.9 | 4.9 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
4.9 | 43.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
4.9 | 9.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
4.9 | 14.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
4.8 | 19.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
4.8 | 24.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
4.8 | 38.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
4.8 | 9.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
4.8 | 19.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
4.8 | 14.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
4.8 | 4.8 | GO:0080009 | mRNA methylation(GO:0080009) |
4.8 | 4.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
4.8 | 14.3 | GO:0097066 | response to thyroid hormone(GO:0097066) |
4.8 | 19.0 | GO:0007144 | female meiosis I(GO:0007144) |
4.7 | 4.7 | GO:0015889 | cobalamin transport(GO:0015889) |
4.7 | 38.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
4.7 | 14.2 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
4.7 | 23.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
4.7 | 14.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
4.7 | 4.7 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
4.7 | 9.4 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
4.7 | 4.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
4.7 | 9.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
4.7 | 56.4 | GO:0045116 | protein neddylation(GO:0045116) |
4.7 | 14.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
4.7 | 4.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
4.7 | 32.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
4.7 | 9.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
4.7 | 9.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
4.7 | 9.3 | GO:0006868 | glutamine transport(GO:0006868) |
4.7 | 18.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
4.7 | 14.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
4.6 | 18.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
4.6 | 32.4 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
4.6 | 18.5 | GO:0061042 | vascular wound healing(GO:0061042) |
4.6 | 13.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
4.6 | 4.6 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
4.6 | 4.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
4.6 | 4.6 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
4.6 | 23.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
4.6 | 18.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
4.6 | 32.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
4.6 | 4.6 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
4.6 | 22.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
4.6 | 13.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
4.6 | 4.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
4.5 | 40.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
4.5 | 31.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
4.5 | 22.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
4.5 | 18.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
4.5 | 13.6 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
4.5 | 22.6 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
4.5 | 18.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
4.5 | 4.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
4.5 | 4.5 | GO:0046782 | regulation of viral transcription(GO:0046782) |
4.5 | 36.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
4.5 | 9.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
4.5 | 4.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
4.5 | 27.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
4.5 | 27.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
4.5 | 22.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
4.5 | 9.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
4.5 | 4.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
4.5 | 8.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
4.5 | 22.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
4.4 | 22.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
4.4 | 4.4 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
4.4 | 8.9 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
4.4 | 8.9 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
4.4 | 39.8 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
4.4 | 4.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
4.4 | 8.8 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
4.4 | 13.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
4.4 | 4.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
4.4 | 26.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
4.4 | 8.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
4.4 | 4.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
4.4 | 4.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
4.4 | 4.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
4.4 | 61.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
4.4 | 4.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
4.4 | 17.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
4.4 | 61.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
4.3 | 39.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
4.3 | 47.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
4.3 | 56.4 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
4.3 | 26.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
4.3 | 8.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
4.3 | 25.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
4.3 | 8.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
4.3 | 13.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
4.3 | 12.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
4.3 | 4.3 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
4.3 | 4.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
4.3 | 4.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
4.3 | 4.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
4.3 | 4.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
4.3 | 4.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
4.3 | 17.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
4.3 | 64.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
4.3 | 12.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
4.3 | 46.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
4.3 | 12.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
4.3 | 8.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
4.3 | 8.5 | GO:0042148 | strand invasion(GO:0042148) |
4.3 | 8.5 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
4.3 | 12.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
4.2 | 29.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
4.2 | 21.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
4.2 | 25.4 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
4.2 | 76.2 | GO:0010761 | fibroblast migration(GO:0010761) |
4.2 | 4.2 | GO:0007000 | nucleolus organization(GO:0007000) |
4.2 | 46.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
4.2 | 12.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
4.2 | 12.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
4.2 | 4.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
4.2 | 42.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
4.2 | 8.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
4.2 | 8.4 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
4.2 | 8.4 | GO:0090009 | primitive streak formation(GO:0090009) |
4.2 | 8.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
4.2 | 4.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
4.2 | 8.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
4.2 | 62.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
4.2 | 74.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
4.2 | 54.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
4.1 | 16.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
4.1 | 8.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
4.1 | 61.9 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
4.1 | 20.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
4.1 | 4.1 | GO:0060914 | heart formation(GO:0060914) |
4.1 | 4.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
4.1 | 8.2 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
4.1 | 20.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
4.1 | 4.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
4.1 | 24.6 | GO:0007097 | nuclear migration(GO:0007097) |
4.1 | 4.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
4.1 | 16.4 | GO:0000012 | single strand break repair(GO:0000012) |
4.1 | 4.1 | GO:0007398 | ectoderm development(GO:0007398) |
4.1 | 8.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
4.1 | 8.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
4.1 | 28.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
4.1 | 12.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
4.1 | 12.2 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
4.1 | 12.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
4.1 | 12.2 | GO:0051775 | response to redox state(GO:0051775) |
4.1 | 4.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
4.1 | 36.5 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
4.1 | 4.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
4.1 | 8.1 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
4.0 | 12.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
4.0 | 36.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
4.0 | 16.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
4.0 | 4.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
4.0 | 4.0 | GO:0031033 | myosin filament organization(GO:0031033) |
4.0 | 8.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
4.0 | 4.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
4.0 | 24.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
4.0 | 24.1 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
4.0 | 12.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
4.0 | 16.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
4.0 | 4.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
4.0 | 12.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
4.0 | 8.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
4.0 | 51.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
4.0 | 8.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
4.0 | 19.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
4.0 | 4.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
4.0 | 15.9 | GO:1903332 | regulation of protein folding(GO:1903332) |
4.0 | 4.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
4.0 | 15.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
4.0 | 11.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
4.0 | 4.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
4.0 | 7.9 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
4.0 | 15.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
4.0 | 19.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
3.9 | 11.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
3.9 | 7.9 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
3.9 | 43.2 | GO:0001945 | lymph vessel development(GO:0001945) |
3.9 | 11.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
3.9 | 43.2 | GO:0035904 | aorta development(GO:0035904) |
3.9 | 11.8 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
3.9 | 47.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
3.9 | 15.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
3.9 | 117.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
3.9 | 3.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
3.9 | 3.9 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
3.9 | 3.9 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
3.9 | 3.9 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
3.9 | 15.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
3.9 | 7.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
3.9 | 7.8 | GO:0003383 | apical constriction(GO:0003383) |
3.9 | 15.5 | GO:0001893 | maternal placenta development(GO:0001893) |
3.9 | 7.8 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
3.9 | 38.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
3.9 | 23.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
3.9 | 7.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
3.9 | 65.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
3.9 | 61.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
3.9 | 11.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
3.8 | 26.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
3.8 | 3.8 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
3.8 | 11.5 | GO:0042737 | drug catabolic process(GO:0042737) |
3.8 | 3.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
3.8 | 23.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
3.8 | 11.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
3.8 | 3.8 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
3.8 | 65.0 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
3.8 | 3.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
3.8 | 61.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
3.8 | 15.2 | GO:0019695 | choline metabolic process(GO:0019695) |
3.8 | 19.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
3.8 | 3.8 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
3.8 | 15.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
3.8 | 11.4 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
3.8 | 11.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
3.8 | 15.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
3.8 | 34.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
3.8 | 3.8 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
3.8 | 18.9 | GO:0015931 | nucleobase-containing compound transport(GO:0015931) |
3.8 | 3.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
3.8 | 37.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
3.8 | 26.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
3.7 | 22.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
3.7 | 26.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
3.7 | 11.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
3.7 | 3.7 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
3.7 | 11.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
3.7 | 7.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
3.7 | 3.7 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
3.7 | 26.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
3.7 | 7.4 | GO:0070268 | cornification(GO:0070268) |
3.7 | 11.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
3.7 | 7.4 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
3.7 | 44.5 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
3.7 | 7.4 | GO:0009189 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
3.7 | 7.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
3.7 | 11.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
3.7 | 51.8 | GO:0017144 | drug metabolic process(GO:0017144) |
3.7 | 25.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
3.7 | 3.7 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
3.7 | 55.3 | GO:0031648 | protein destabilization(GO:0031648) |
3.7 | 18.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
3.7 | 3.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
3.7 | 14.7 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
3.7 | 25.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
3.7 | 11.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
3.7 | 22.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
3.7 | 11.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.7 | 7.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
3.7 | 62.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
3.6 | 14.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
3.6 | 69.2 | GO:0007520 | myoblast fusion(GO:0007520) |
3.6 | 7.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
3.6 | 7.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
3.6 | 25.5 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
3.6 | 3.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
3.6 | 25.3 | GO:0051383 | kinetochore organization(GO:0051383) |
3.6 | 10.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
3.6 | 3.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
3.6 | 18.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
3.6 | 7.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
3.6 | 36.0 | GO:0070166 | enamel mineralization(GO:0070166) |
3.6 | 14.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
3.6 | 3.6 | GO:0008105 | asymmetric protein localization(GO:0008105) |
3.6 | 3.6 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
3.6 | 35.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
3.6 | 17.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
3.6 | 3.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
3.6 | 57.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
3.6 | 21.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
3.6 | 3.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
3.6 | 28.5 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
3.5 | 14.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
3.5 | 17.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
3.5 | 10.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
3.5 | 10.6 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
3.5 | 17.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
3.5 | 17.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
3.5 | 73.9 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
3.5 | 49.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
3.5 | 3.5 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
3.5 | 7.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
3.5 | 7.0 | GO:0015819 | lysine transport(GO:0015819) |
3.5 | 20.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
3.5 | 10.5 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
3.5 | 3.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.5 | 10.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
3.5 | 6.9 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
3.5 | 6.9 | GO:0033622 | integrin activation(GO:0033622) |
3.5 | 6.9 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
3.5 | 17.3 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
3.5 | 20.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
3.4 | 10.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
3.4 | 13.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
3.4 | 10.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
3.4 | 3.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
3.4 | 6.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
3.4 | 10.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
3.4 | 6.9 | GO:0030242 | pexophagy(GO:0030242) |
3.4 | 3.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
3.4 | 3.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
3.4 | 3.4 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
3.4 | 6.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
3.4 | 3.4 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
3.4 | 10.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
3.4 | 3.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
3.4 | 40.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
3.4 | 3.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
3.4 | 10.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
3.4 | 27.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
3.4 | 16.9 | GO:0009650 | UV protection(GO:0009650) |
3.4 | 23.6 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
3.4 | 30.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
3.4 | 13.5 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
3.4 | 10.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
3.4 | 3.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
3.4 | 40.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
3.3 | 13.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
3.3 | 10.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
3.3 | 13.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
3.3 | 10.0 | GO:0016264 | gap junction assembly(GO:0016264) |
3.3 | 3.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
3.3 | 26.6 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
3.3 | 19.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
3.3 | 6.6 | GO:0007379 | segment specification(GO:0007379) |
3.3 | 26.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
3.3 | 26.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
3.3 | 19.9 | GO:0016556 | mRNA modification(GO:0016556) |
3.3 | 19.9 | GO:0032096 | negative regulation of response to food(GO:0032096) |
3.3 | 9.9 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
3.3 | 6.6 | GO:0006833 | water transport(GO:0006833) |
3.3 | 33.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
3.3 | 9.9 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
3.3 | 9.8 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
3.3 | 22.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
3.3 | 9.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
3.3 | 42.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
3.3 | 6.5 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
3.2 | 3.2 | GO:0006949 | syncytium formation(GO:0006949) |
3.2 | 6.5 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
3.2 | 9.7 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
3.2 | 9.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
3.2 | 3.2 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
3.2 | 3.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
3.2 | 9.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
3.2 | 6.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
3.2 | 6.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
3.2 | 57.5 | GO:0030168 | platelet activation(GO:0030168) |
3.2 | 9.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
3.2 | 38.3 | GO:0045214 | sarcomere organization(GO:0045214) |
3.2 | 38.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
3.2 | 3.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
3.2 | 25.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
3.2 | 6.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
3.2 | 15.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
3.2 | 3.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
3.2 | 3.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
3.2 | 9.5 | GO:0009299 | mRNA transcription(GO:0009299) |
3.2 | 28.5 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
3.2 | 6.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
3.2 | 9.5 | GO:0051231 | spindle elongation(GO:0051231) |
3.2 | 6.3 | GO:0001555 | oocyte growth(GO:0001555) |
3.2 | 3.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
3.1 | 3.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
3.1 | 3.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
3.1 | 15.7 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
3.1 | 6.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
3.1 | 9.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
3.1 | 18.8 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
3.1 | 3.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
3.1 | 12.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
3.1 | 9.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
3.1 | 28.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
3.1 | 6.2 | GO:0043084 | penile erection(GO:0043084) |
3.1 | 3.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
3.1 | 90.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
3.1 | 6.2 | GO:1903232 | melanosome assembly(GO:1903232) |
3.1 | 6.2 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
3.1 | 3.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
3.1 | 6.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
3.1 | 12.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
3.1 | 3.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
3.1 | 37.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
3.1 | 9.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
3.1 | 3.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
3.1 | 9.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
3.1 | 15.4 | GO:0060539 | diaphragm development(GO:0060539) |
3.1 | 27.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
3.1 | 12.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
3.1 | 52.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
3.1 | 12.2 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
3.1 | 12.2 | GO:0042168 | heme metabolic process(GO:0042168) |
3.1 | 3.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
3.0 | 15.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
3.0 | 15.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
3.0 | 18.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
3.0 | 24.3 | GO:0032438 | melanosome organization(GO:0032438) |
3.0 | 9.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
3.0 | 9.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
3.0 | 3.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
3.0 | 6.1 | GO:0032570 | response to progesterone(GO:0032570) |
3.0 | 6.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
3.0 | 3.0 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
3.0 | 15.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
3.0 | 12.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
3.0 | 6.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
3.0 | 3.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
3.0 | 9.0 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
3.0 | 15.0 | GO:0009249 | protein lipoylation(GO:0009249) |
3.0 | 15.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
3.0 | 6.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
3.0 | 29.8 | GO:0045047 | protein targeting to ER(GO:0045047) |
3.0 | 3.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
3.0 | 3.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
3.0 | 3.0 | GO:0032642 | regulation of chemokine production(GO:0032642) |
3.0 | 8.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
3.0 | 6.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
3.0 | 3.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
3.0 | 5.9 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
3.0 | 109.9 | GO:0016125 | sterol metabolic process(GO:0016125) |
3.0 | 23.8 | GO:0034030 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
3.0 | 5.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
3.0 | 20.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
3.0 | 8.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
3.0 | 5.9 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
2.9 | 11.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
2.9 | 87.9 | GO:0055088 | lipid homeostasis(GO:0055088) |
2.9 | 2.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
2.9 | 8.8 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
2.9 | 5.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.9 | 20.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
2.9 | 26.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
2.9 | 2.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
2.9 | 5.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.9 | 8.7 | GO:0048539 | bone marrow development(GO:0048539) |
2.9 | 2.9 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
2.9 | 2.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
2.9 | 2.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
2.9 | 5.8 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
2.9 | 17.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
2.9 | 28.8 | GO:0042407 | cristae formation(GO:0042407) |
2.9 | 37.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
2.9 | 20.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
2.9 | 2.9 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
2.9 | 8.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
2.9 | 5.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
2.9 | 5.7 | GO:0015669 | gas transport(GO:0015669) |
2.9 | 14.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
2.9 | 17.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
2.8 | 11.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
2.8 | 8.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.8 | 5.7 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
2.8 | 5.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.8 | 19.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
2.8 | 45.2 | GO:0006953 | acute-phase response(GO:0006953) |
2.8 | 5.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
2.8 | 19.7 | GO:0031167 | rRNA methylation(GO:0031167) |
2.8 | 5.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
2.8 | 5.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
2.8 | 2.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.8 | 11.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
2.8 | 5.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
2.8 | 5.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
2.8 | 2.8 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
2.8 | 2.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.8 | 5.6 | GO:0008209 | androgen metabolic process(GO:0008209) |
2.8 | 16.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
2.8 | 2.8 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
2.8 | 8.3 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
2.8 | 5.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
2.8 | 13.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
2.8 | 19.3 | GO:0009648 | photoperiodism(GO:0009648) |
2.7 | 2.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
2.7 | 8.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
2.7 | 11.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
2.7 | 5.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
2.7 | 5.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.7 | 62.7 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
2.7 | 2.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
2.7 | 19.0 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
2.7 | 13.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
2.7 | 2.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
2.7 | 16.3 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
2.7 | 27.2 | GO:0061515 | myeloid cell development(GO:0061515) |
2.7 | 5.4 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.7 | 8.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
2.7 | 10.8 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
2.7 | 8.1 | GO:0019079 | viral genome replication(GO:0019079) |
2.7 | 21.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
2.7 | 10.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.7 | 16.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
2.7 | 2.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
2.7 | 21.5 | GO:0030261 | chromosome condensation(GO:0030261) |
2.7 | 24.2 | GO:0048535 | lymph node development(GO:0048535) |
2.7 | 8.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
2.7 | 5.4 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
2.7 | 18.8 | GO:0007569 | cell aging(GO:0007569) |
2.7 | 45.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
2.7 | 26.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
2.7 | 5.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
2.7 | 5.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
2.7 | 5.3 | GO:0019042 | viral latency(GO:0019042) |
2.7 | 61.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
2.7 | 8.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
2.7 | 61.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
2.7 | 47.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
2.7 | 5.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
2.6 | 18.5 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
2.6 | 7.9 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
2.6 | 2.6 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
2.6 | 18.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
2.6 | 13.2 | GO:0000154 | rRNA modification(GO:0000154) |
2.6 | 5.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
2.6 | 2.6 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
2.6 | 20.9 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
2.6 | 10.5 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
2.6 | 7.8 | GO:0001302 | replicative cell aging(GO:0001302) |
2.6 | 20.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
2.6 | 15.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
2.6 | 5.2 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
2.6 | 2.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
2.6 | 15.6 | GO:0097286 | iron ion import(GO:0097286) |
2.6 | 5.2 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
2.6 | 13.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
2.6 | 10.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
2.6 | 5.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
2.6 | 7.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
2.6 | 20.7 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
2.6 | 12.9 | GO:0051013 | microtubule severing(GO:0051013) |
2.6 | 43.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
2.6 | 5.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
2.6 | 18.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
2.6 | 2.6 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
2.6 | 2.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.6 | 2.6 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
2.6 | 15.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
2.6 | 56.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
2.6 | 20.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
2.5 | 28.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
2.5 | 2.5 | GO:0006007 | glucose catabolic process(GO:0006007) |
2.5 | 81.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
2.5 | 2.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
2.5 | 96.5 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
2.5 | 7.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
2.5 | 10.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.5 | 5.0 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
2.5 | 27.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
2.5 | 17.6 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
2.5 | 15.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
2.5 | 2.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
2.5 | 2.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
2.5 | 2.5 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
2.5 | 2.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.5 | 12.5 | GO:1904970 | brush border assembly(GO:1904970) |
2.5 | 25.0 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
2.5 | 2.5 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
2.5 | 131.9 | GO:0051236 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
2.5 | 5.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
2.5 | 24.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
2.5 | 39.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
2.5 | 9.8 | GO:0007141 | male meiosis I(GO:0007141) |
2.5 | 4.9 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
2.5 | 7.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
2.4 | 66.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
2.4 | 2.4 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
2.4 | 12.2 | GO:0051026 | chiasma assembly(GO:0051026) |
2.4 | 19.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
2.4 | 2.4 | GO:0070989 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
2.4 | 7.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
2.4 | 2.4 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
2.4 | 2.4 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
2.4 | 82.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
2.4 | 4.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
2.4 | 4.8 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
2.4 | 2.4 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
2.4 | 14.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
2.4 | 38.5 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
2.4 | 134.7 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
2.4 | 31.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
2.4 | 9.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
2.4 | 33.5 | GO:0016575 | histone deacetylation(GO:0016575) |
2.4 | 2.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
2.4 | 4.8 | GO:0002215 | defense response to nematode(GO:0002215) |
2.4 | 9.5 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
2.4 | 4.7 | GO:0040031 | snRNA modification(GO:0040031) |
2.4 | 11.8 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
2.4 | 2.4 | GO:0001562 | response to protozoan(GO:0001562) |
2.4 | 16.5 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
2.4 | 7.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
2.3 | 11.7 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
2.3 | 18.7 | GO:0072678 | T cell migration(GO:0072678) |
2.3 | 7.0 | GO:1903276 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
2.3 | 46.6 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
2.3 | 32.5 | GO:0060325 | face morphogenesis(GO:0060325) |
2.3 | 16.2 | GO:0031929 | TOR signaling(GO:0031929) |
2.3 | 9.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
2.3 | 6.9 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
2.3 | 32.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
2.3 | 60.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
2.3 | 4.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
2.3 | 23.1 | GO:0043489 | RNA stabilization(GO:0043489) |
2.3 | 9.2 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
2.3 | 2.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
2.3 | 11.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
2.3 | 11.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
2.3 | 6.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
2.3 | 38.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
2.3 | 2.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
2.3 | 6.8 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
2.3 | 4.6 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
2.3 | 27.3 | GO:0016073 | snRNA metabolic process(GO:0016073) |
2.3 | 6.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
2.3 | 20.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
2.3 | 6.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
2.3 | 27.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
2.2 | 2.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
2.2 | 6.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.2 | 13.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
2.2 | 2.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
2.2 | 4.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
2.2 | 4.5 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
2.2 | 13.4 | GO:0070269 | pyroptosis(GO:0070269) |
2.2 | 24.4 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
2.2 | 8.9 | GO:0043206 | extracellular fibril organization(GO:0043206) |
2.2 | 2.2 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
2.2 | 8.8 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
2.2 | 15.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
2.2 | 2.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
2.2 | 2.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
2.2 | 17.4 | GO:1901998 | toxin transport(GO:1901998) |
2.2 | 69.6 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
2.2 | 4.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
2.2 | 4.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
2.2 | 2.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
2.2 | 4.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
2.2 | 10.8 | GO:0001771 | immunological synapse formation(GO:0001771) |
2.1 | 8.5 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
2.1 | 2.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
2.1 | 2.1 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of chromosome segregation(GO:0051985) |
2.1 | 19.1 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
2.1 | 2.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
2.1 | 8.5 | GO:0006903 | vesicle targeting(GO:0006903) |
2.1 | 4.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
2.1 | 6.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.1 | 65.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
2.1 | 6.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
2.1 | 4.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
2.1 | 6.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
2.1 | 6.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
2.1 | 4.2 | GO:0001757 | somite specification(GO:0001757) |
2.1 | 25.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
2.1 | 12.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
2.1 | 10.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
2.1 | 4.1 | GO:0070266 | necroptotic process(GO:0070266) |
2.1 | 6.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
2.1 | 6.2 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
2.1 | 20.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
2.1 | 2.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.0 | 2.0 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
2.0 | 16.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
2.0 | 2.0 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
2.0 | 85.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
2.0 | 4.1 | GO:0033572 | transferrin transport(GO:0033572) |
2.0 | 14.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
2.0 | 2.0 | GO:0090656 | t-circle formation(GO:0090656) |
2.0 | 6.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
2.0 | 8.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.0 | 8.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
2.0 | 13.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
2.0 | 17.9 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
2.0 | 4.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
2.0 | 4.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
2.0 | 2.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
2.0 | 27.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
1.9 | 3.9 | GO:0044838 | cell quiescence(GO:0044838) |
1.9 | 5.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.9 | 17.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
1.9 | 17.4 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
1.9 | 3.9 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
1.9 | 9.6 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
1.9 | 5.8 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.9 | 1.9 | GO:0015791 | polyol transport(GO:0015791) |
1.9 | 34.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.9 | 1.9 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
1.9 | 3.8 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
1.9 | 7.6 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.9 | 9.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.9 | 11.4 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
1.9 | 39.9 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
1.9 | 34.2 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
1.9 | 3.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.9 | 22.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.9 | 1.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.9 | 5.6 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.9 | 3.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.9 | 1.9 | GO:0048865 | stem cell fate commitment(GO:0048865) |
1.9 | 61.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.9 | 40.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
1.9 | 13.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
1.8 | 12.9 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
1.8 | 5.5 | GO:0042755 | eating behavior(GO:0042755) |
1.8 | 1.8 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
1.8 | 16.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
1.8 | 1.8 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
1.8 | 1.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.8 | 12.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.8 | 9.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
1.8 | 43.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.8 | 5.4 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
1.8 | 3.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.8 | 7.2 | GO:1901992 | positive regulation of mitotic cell cycle phase transition(GO:1901992) |
1.8 | 5.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.8 | 9.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.8 | 7.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
1.8 | 3.6 | GO:0070542 | response to fatty acid(GO:0070542) |
1.8 | 5.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
1.8 | 5.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
1.8 | 5.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
1.8 | 7.0 | GO:0060840 | artery development(GO:0060840) |
1.8 | 5.3 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
1.8 | 24.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
1.8 | 14.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.7 | 5.2 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
1.7 | 3.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.7 | 1.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
1.7 | 5.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
1.7 | 1.7 | GO:0051657 | maintenance of organelle location(GO:0051657) |
1.7 | 1.7 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.7 | 5.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.7 | 13.8 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
1.7 | 3.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
1.7 | 5.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
1.7 | 3.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.7 | 5.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.7 | 8.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.7 | 8.5 | GO:0002176 | male germ cell proliferation(GO:0002176) |
1.7 | 8.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
1.7 | 10.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
1.7 | 3.4 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
1.7 | 33.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
1.7 | 1.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
1.7 | 1.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
1.7 | 1.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.7 | 1.7 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
1.7 | 1.7 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
1.7 | 3.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.7 | 11.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
1.6 | 6.6 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.6 | 14.8 | GO:0051168 | nuclear export(GO:0051168) |
1.6 | 18.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
1.6 | 24.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
1.6 | 3.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.6 | 6.5 | GO:0050832 | defense response to fungus(GO:0050832) |
1.6 | 3.3 | GO:1990266 | neutrophil migration(GO:1990266) |
1.6 | 1.6 | GO:0015747 | urate transport(GO:0015747) |
1.6 | 52.0 | GO:0007052 | mitotic spindle organization(GO:0007052) |
1.6 | 1.6 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of glucocorticoid secretion(GO:2000851) |
1.6 | 17.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.6 | 3.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
1.6 | 6.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.6 | 1.6 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
1.6 | 3.2 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
1.6 | 8.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.6 | 1.6 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.6 | 3.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.6 | 3.2 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
1.6 | 1.6 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
1.6 | 11.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
1.6 | 1.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.6 | 34.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.6 | 1.6 | GO:0072718 | response to cisplatin(GO:0072718) |
1.6 | 40.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.6 | 9.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.6 | 1.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.6 | 9.3 | GO:0006284 | base-excision repair(GO:0006284) |
1.6 | 6.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.6 | 20.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.6 | 4.7 | GO:0009988 | cell-cell recognition(GO:0009988) |
1.6 | 1.6 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.6 | 10.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
1.5 | 21.7 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
1.5 | 3.1 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
1.5 | 7.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
1.5 | 34.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
1.5 | 17.0 | GO:0007588 | excretion(GO:0007588) |
1.5 | 3.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
1.5 | 30.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.5 | 1.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.5 | 3.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.5 | 1.5 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
1.5 | 16.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
1.5 | 3.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
1.5 | 1.5 | GO:0009994 | oocyte differentiation(GO:0009994) |
1.5 | 1.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.5 | 1.5 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
1.5 | 1.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
1.5 | 3.0 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
1.5 | 1.5 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
1.5 | 16.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
1.5 | 7.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.5 | 3.0 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
1.5 | 15.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
1.5 | 3.0 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
1.5 | 3.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.5 | 1.5 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
1.5 | 1.5 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
1.5 | 3.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
1.5 | 6.0 | GO:0006968 | cellular defense response(GO:0006968) |
1.5 | 1.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.5 | 6.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.5 | 3.0 | GO:0034505 | tooth mineralization(GO:0034505) |
1.5 | 4.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
1.5 | 4.4 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.5 | 2.9 | GO:0010039 | response to iron ion(GO:0010039) |
1.5 | 7.3 | GO:0030104 | water homeostasis(GO:0030104) |
1.5 | 22.0 | GO:0006491 | N-glycan processing(GO:0006491) |
1.5 | 1.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.5 | 2.9 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
1.5 | 13.1 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.5 | 29.1 | GO:0031424 | keratinization(GO:0031424) |
1.5 | 4.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
1.4 | 67.8 | GO:0032259 | methylation(GO:0032259) |
1.4 | 2.9 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
1.4 | 11.5 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
1.4 | 1.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.4 | 2.9 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
1.4 | 8.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
1.4 | 2.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.4 | 7.1 | GO:0001706 | endoderm formation(GO:0001706) |
1.4 | 22.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
1.4 | 4.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.4 | 4.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.4 | 1.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
1.4 | 15.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
1.4 | 1.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.4 | 1.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.4 | 23.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
1.4 | 22.4 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
1.4 | 2.8 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
1.4 | 5.5 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
1.4 | 33.2 | GO:0098840 | protein transport along microtubule(GO:0098840) |
1.4 | 17.8 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
1.4 | 1.4 | GO:0032673 | regulation of interleukin-4 production(GO:0032673) |
1.4 | 2.7 | GO:0003352 | regulation of cilium movement(GO:0003352) |
1.4 | 4.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
1.4 | 20.4 | GO:0015914 | phospholipid transport(GO:0015914) |
1.4 | 4.1 | GO:0007126 | meiotic nuclear division(GO:0007126) |
1.4 | 15.0 | GO:0019835 | cytolysis(GO:0019835) |
1.4 | 20.4 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
1.4 | 2.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.4 | 1.4 | GO:0060676 | ureteric bud formation(GO:0060676) |
1.4 | 9.5 | GO:0045445 | myoblast differentiation(GO:0045445) |
1.3 | 1.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
1.3 | 28.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
1.3 | 2.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.3 | 5.4 | GO:0042255 | ribosome assembly(GO:0042255) |
1.3 | 48.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
1.3 | 8.0 | GO:0032060 | bleb assembly(GO:0032060) |
1.3 | 10.7 | GO:0044804 | nucleophagy(GO:0044804) |
1.3 | 25.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
1.3 | 120.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
1.3 | 4.0 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
1.3 | 2.7 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
1.3 | 4.0 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.3 | 5.3 | GO:0098534 | centriole assembly(GO:0098534) |
1.3 | 2.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
1.3 | 2.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
1.3 | 2.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.3 | 3.9 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
1.3 | 27.3 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
1.3 | 1.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
1.3 | 11.6 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
1.3 | 15.5 | GO:0016573 | histone acetylation(GO:0016573) |
1.3 | 3.9 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
1.3 | 6.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.3 | 25.5 | GO:0030042 | actin filament depolymerization(GO:0030042) |
1.3 | 8.9 | GO:0016926 | protein desumoylation(GO:0016926) |
1.3 | 38.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
1.3 | 2.5 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
1.3 | 1.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.3 | 10.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.3 | 2.5 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
1.2 | 2.5 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.2 | 2.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
1.2 | 7.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.2 | 2.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.2 | 8.6 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
1.2 | 2.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
1.2 | 3.7 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.2 | 199.9 | GO:0008380 | RNA splicing(GO:0008380) |
1.2 | 2.4 | GO:0043687 | post-translational protein modification(GO:0043687) |
1.2 | 2.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.2 | 6.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.2 | 1.2 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
1.2 | 6.0 | GO:0032355 | response to estradiol(GO:0032355) |
1.2 | 4.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.2 | 2.4 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
1.2 | 3.6 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.2 | 1.2 | GO:0051132 | NK T cell activation(GO:0051132) |
1.2 | 1.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
1.2 | 7.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
1.2 | 30.5 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
1.2 | 1.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.2 | 3.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.2 | 7.0 | GO:0015893 | drug transport(GO:0015893) |
1.2 | 4.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
1.2 | 1.2 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
1.2 | 5.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.2 | 9.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.2 | 6.9 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
1.1 | 1.1 | GO:0015884 | folic acid transport(GO:0015884) |
1.1 | 1.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) positive regulation of monocyte differentiation(GO:0045657) |
1.1 | 4.6 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.1 | 4.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
1.1 | 16.8 | GO:0007051 | spindle organization(GO:0007051) |
1.1 | 3.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.1 | 2.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.1 | 5.5 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
1.1 | 6.6 | GO:0002327 | immature B cell differentiation(GO:0002327) |
1.1 | 4.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
1.1 | 7.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
1.1 | 1.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
1.1 | 6.6 | GO:0051321 | meiotic cell cycle(GO:0051321) |
1.1 | 4.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
1.1 | 5.5 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
1.1 | 3.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.1 | 2.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
1.1 | 2.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.1 | 3.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
1.1 | 2.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.1 | 2.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
1.1 | 19.1 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) |
1.1 | 19.1 | GO:0007596 | blood coagulation(GO:0007596) |
1.1 | 1.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.1 | 3.2 | GO:0072189 | ureter development(GO:0072189) |
1.1 | 2.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
1.1 | 5.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
1.1 | 5.3 | GO:0006997 | nucleus organization(GO:0006997) |
1.1 | 2.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
1.0 | 3.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
1.0 | 3.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
1.0 | 1.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.0 | 7.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.0 | 1.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
1.0 | 2.1 | GO:0033280 | response to vitamin D(GO:0033280) |
1.0 | 1.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
1.0 | 36.9 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
1.0 | 3.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.0 | 30.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
1.0 | 80.6 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
1.0 | 3.1 | GO:0001759 | organ induction(GO:0001759) |
1.0 | 3.0 | GO:0046415 | urate metabolic process(GO:0046415) |
1.0 | 6.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
1.0 | 43.4 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
1.0 | 4.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.0 | 7.1 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
1.0 | 2.0 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
1.0 | 24.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.0 | 2.0 | GO:0051346 | negative regulation of hydrolase activity(GO:0051346) |
1.0 | 1.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
1.0 | 4.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
1.0 | 1.0 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
1.0 | 2.9 | GO:0060438 | trachea development(GO:0060438) |
1.0 | 7.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
1.0 | 7.7 | GO:0048144 | fibroblast proliferation(GO:0048144) |
1.0 | 5.8 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.0 | 78.5 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
1.0 | 2.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.9 | 5.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.9 | 8.5 | GO:0007492 | endoderm development(GO:0007492) |
0.9 | 0.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.9 | 0.9 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.9 | 5.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.9 | 0.9 | GO:0048069 | eye pigmentation(GO:0048069) |
0.9 | 1.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.9 | 0.9 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.9 | 36.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.9 | 2.7 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.9 | 9.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.9 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.9 | 1.8 | GO:1901317 | regulation of sperm motility(GO:1901317) positive regulation of sperm motility(GO:1902093) |
0.9 | 0.9 | GO:0070459 | prolactin secretion(GO:0070459) |
0.9 | 20.6 | GO:0006310 | DNA recombination(GO:0006310) |
0.9 | 1.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.9 | 150.6 | GO:0006412 | translation(GO:0006412) |
0.9 | 1.8 | GO:0032098 | regulation of appetite(GO:0032098) |
0.9 | 2.6 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.9 | 0.9 | GO:0097186 | amelogenesis(GO:0097186) |
0.9 | 7.0 | GO:0071467 | cellular response to pH(GO:0071467) |
0.9 | 2.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.9 | 6.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.8 | 0.8 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.8 | 1.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.8 | 10.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.8 | 2.5 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.8 | 2.5 | GO:0045123 | cellular extravasation(GO:0045123) |
0.8 | 3.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.8 | 17.0 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.8 | 2.4 | GO:0001556 | oocyte maturation(GO:0001556) |
0.8 | 51.6 | GO:0006954 | inflammatory response(GO:0006954) |
0.8 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.8 | 3.9 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.8 | 4.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.8 | 1.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.8 | 21.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.8 | 5.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.8 | 6.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.8 | 5.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.7 | 4.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.7 | 3.7 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.7 | 2.2 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.7 | 0.7 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.7 | 0.7 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.7 | 2.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.7 | 0.7 | GO:0045621 | positive regulation of lymphocyte differentiation(GO:0045621) |
0.7 | 23.0 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.7 | 0.7 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.7 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 1.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.7 | 4.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.7 | 0.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.7 | 1.3 | GO:0051196 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.6 | 1.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.6 | 2.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.6 | 2.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.6 | 1.3 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.6 | 1.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.6 | 1.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.6 | 0.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.6 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.6 | 3.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.6 | 1.9 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.6 | 4.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.6 | 0.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.6 | 0.6 | GO:0046631 | alpha-beta T cell activation(GO:0046631) |
0.6 | 1.2 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.6 | 0.6 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.6 | 1.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.6 | 3.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.6 | 27.8 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.6 | 0.6 | GO:0009620 | response to fungus(GO:0009620) |
0.6 | 0.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.6 | 0.6 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.6 | 2.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.6 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.6 | 1.7 | GO:0050810 | regulation of lipid biosynthetic process(GO:0046890) regulation of steroid biosynthetic process(GO:0050810) |
0.6 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.6 | 0.6 | GO:0009624 | response to nematode(GO:0009624) |
0.6 | 21.6 | GO:0006457 | protein folding(GO:0006457) |
0.5 | 16.5 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.5 | 94.5 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.5 | 12.0 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.5 | 1.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.5 | 0.5 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.5 | 3.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.5 | 0.5 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 0.5 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.5 | 0.5 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.5 | 4.1 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.5 | 0.5 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.5 | 1.5 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.5 | 3.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.5 | 30.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.5 | 4.8 | GO:0007602 | phototransduction(GO:0007602) |
0.5 | 1.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 11.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.5 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.5 | 2.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.5 | 4.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.5 | 3.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 0.9 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 0.4 | GO:0010712 | regulation of collagen metabolic process(GO:0010712) |
0.4 | 2.6 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.4 | 0.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.4 | 17.7 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.4 | 0.4 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.4 | 0.4 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.4 | 0.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.4 | 0.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.4 | 0.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 0.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 3.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.4 | 14.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.4 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 27.1 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.4 | 2.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.3 | 3.1 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.3 | 0.3 | GO:0045924 | regulation of female receptivity(GO:0045924) |
0.3 | 1.0 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.3 | 1.0 | GO:0007584 | response to nutrient(GO:0007584) |
0.3 | 0.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 1.3 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.3 | 8.7 | GO:0006281 | DNA repair(GO:0006281) |
0.3 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 10.7 | GO:0045087 | innate immune response(GO:0045087) |
0.3 | 0.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.3 | 0.9 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 0.3 | GO:1901616 | organic hydroxy compound catabolic process(GO:1901616) |
0.3 | 0.6 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.3 | 0.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 0.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 4.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.2 | 0.5 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
0.2 | 2.3 | GO:0001824 | blastocyst development(GO:0001824) |
0.2 | 0.7 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.2 | 0.7 | GO:0031331 | positive regulation of cellular catabolic process(GO:0031331) |
0.2 | 0.9 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.2 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 8.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 7.6 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 10.2 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 0.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 0.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 2.1 | GO:0015749 | monosaccharide transport(GO:0015749) |
0.2 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.6 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.2 | 15.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.6 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 1.7 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.1 | 115.7 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.1 | 0.1 | GO:0044033 | multi-organism metabolic process(GO:0044033) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.3 | GO:0007098 | centrosome cycle(GO:0007098) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.7 | 153.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
21.0 | 63.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
21.0 | 21.0 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
19.3 | 96.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
17.0 | 84.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
16.9 | 84.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
16.2 | 64.6 | GO:1990130 | Iml1 complex(GO:1990130) |
15.9 | 47.7 | GO:0097443 | sorting endosome(GO:0097443) |
15.5 | 62.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
15.3 | 61.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
15.0 | 119.9 | GO:0030056 | hemidesmosome(GO:0030056) |
15.0 | 74.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
14.8 | 59.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
14.8 | 14.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
14.7 | 44.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
12.6 | 63.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
12.6 | 50.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
12.4 | 49.7 | GO:0072487 | MSL complex(GO:0072487) |
12.2 | 12.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
12.1 | 36.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
11.9 | 35.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
11.7 | 128.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
11.7 | 35.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
11.4 | 22.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
11.4 | 56.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
11.3 | 22.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
11.3 | 34.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
11.3 | 22.7 | GO:0031090 | organelle membrane(GO:0031090) |
11.3 | 90.1 | GO:0005861 | troponin complex(GO:0005861) |
11.0 | 21.9 | GO:0031523 | Myb complex(GO:0031523) |
10.8 | 32.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
10.4 | 31.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
10.2 | 20.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
10.2 | 10.2 | GO:0043679 | axon terminus(GO:0043679) neuron projection terminus(GO:0044306) |
10.1 | 10.1 | GO:0000322 | storage vacuole(GO:0000322) |
10.0 | 30.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
9.9 | 29.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
9.9 | 69.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
9.5 | 57.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
9.5 | 47.6 | GO:0005638 | lamin filament(GO:0005638) |
9.2 | 18.4 | GO:0031252 | cell leading edge(GO:0031252) |
9.2 | 9.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
9.1 | 91.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
9.0 | 9.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
8.6 | 8.6 | GO:0005914 | spot adherens junction(GO:0005914) |
8.6 | 43.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
8.5 | 25.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
8.4 | 16.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
8.3 | 41.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
8.2 | 57.5 | GO:0042382 | paraspeckles(GO:0042382) |
8.1 | 187.0 | GO:0008305 | integrin complex(GO:0008305) |
8.1 | 40.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
8.0 | 24.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
8.0 | 47.9 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
7.9 | 31.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
7.9 | 637.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
7.8 | 85.8 | GO:0031528 | microvillus membrane(GO:0031528) |
7.7 | 23.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
7.5 | 37.7 | GO:0061617 | MICOS complex(GO:0061617) |
7.4 | 59.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
7.4 | 81.0 | GO:0002102 | podosome(GO:0002102) |
7.3 | 29.4 | GO:0030914 | STAGA complex(GO:0030914) |
7.3 | 7.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
7.3 | 51.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
7.3 | 51.2 | GO:0005916 | fascia adherens(GO:0005916) |
7.3 | 95.0 | GO:0043034 | costamere(GO:0043034) |
7.3 | 14.6 | GO:0044292 | dendrite terminus(GO:0044292) |
7.2 | 7.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
7.2 | 21.6 | GO:0097413 | Lewy body(GO:0097413) |
7.1 | 142.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
7.1 | 64.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
7.1 | 7.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
7.1 | 56.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
7.0 | 49.3 | GO:0031931 | TORC1 complex(GO:0031931) |
7.0 | 21.1 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
7.0 | 21.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
7.0 | 307.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
7.0 | 41.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
6.9 | 20.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
6.7 | 20.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
6.7 | 13.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
6.6 | 33.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
6.6 | 13.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
6.5 | 19.5 | GO:1990635 | proximal dendrite(GO:1990635) |
6.5 | 39.0 | GO:0097470 | ribbon synapse(GO:0097470) |
6.5 | 6.5 | GO:0097452 | GAIT complex(GO:0097452) |
6.5 | 45.4 | GO:0045179 | apical cortex(GO:0045179) |
6.5 | 12.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
6.4 | 25.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
6.4 | 57.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
6.4 | 89.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
6.4 | 249.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
6.4 | 6.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
6.4 | 50.8 | GO:0042641 | actomyosin(GO:0042641) |
6.3 | 69.3 | GO:0031430 | M band(GO:0031430) |
6.3 | 6.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
6.3 | 31.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
6.3 | 37.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
6.3 | 25.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
6.3 | 287.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
6.2 | 6.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
6.2 | 24.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
6.2 | 12.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
6.2 | 36.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
6.1 | 12.3 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
6.1 | 24.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
6.0 | 24.1 | GO:1990246 | uniplex complex(GO:1990246) |
6.0 | 17.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
5.9 | 329.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
5.8 | 17.5 | GO:1990462 | omegasome(GO:1990462) |
5.8 | 173.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
5.8 | 40.5 | GO:0001650 | fibrillar center(GO:0001650) |
5.8 | 98.1 | GO:0031672 | A band(GO:0031672) |
5.8 | 11.5 | GO:0030870 | Mre11 complex(GO:0030870) |
5.8 | 17.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
5.7 | 126.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
5.7 | 5.7 | GO:0000346 | transcription export complex(GO:0000346) |
5.7 | 17.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
5.6 | 5.6 | GO:0034464 | BBSome(GO:0034464) |
5.6 | 61.7 | GO:0035102 | PRC1 complex(GO:0035102) |
5.6 | 16.8 | GO:1990423 | RZZ complex(GO:1990423) |
5.6 | 44.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
5.6 | 16.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
5.6 | 22.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
5.6 | 105.6 | GO:0000242 | pericentriolar material(GO:0000242) |
5.5 | 33.2 | GO:0031932 | TORC2 complex(GO:0031932) |
5.5 | 11.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
5.5 | 5.5 | GO:0000125 | PCAF complex(GO:0000125) |
5.5 | 22.0 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
5.5 | 16.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
5.5 | 60.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
5.5 | 22.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
5.5 | 109.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
5.5 | 443.1 | GO:0072562 | blood microparticle(GO:0072562) |
5.4 | 70.6 | GO:0000974 | Prp19 complex(GO:0000974) |
5.4 | 21.7 | GO:0071439 | clathrin complex(GO:0071439) |
5.4 | 5.4 | GO:0032432 | actin filament bundle(GO:0032432) |
5.4 | 10.8 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
5.4 | 27.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
5.4 | 5.4 | GO:0005686 | U2 snRNP(GO:0005686) |
5.3 | 26.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
5.3 | 47.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
5.3 | 26.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
5.3 | 21.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
5.3 | 36.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
5.2 | 109.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
5.2 | 15.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
5.2 | 15.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
5.2 | 274.9 | GO:0005811 | lipid particle(GO:0005811) |
5.1 | 15.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
5.1 | 20.4 | GO:0035363 | histone locus body(GO:0035363) |
5.1 | 10.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
5.1 | 10.1 | GO:0033263 | CORVET complex(GO:0033263) |
5.1 | 15.2 | GO:0044194 | cytolytic granule(GO:0044194) |
5.1 | 45.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
5.0 | 15.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
5.0 | 35.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
5.0 | 85.4 | GO:0045120 | pronucleus(GO:0045120) |
5.0 | 40.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
5.0 | 10.0 | GO:0005579 | membrane attack complex(GO:0005579) |
5.0 | 69.8 | GO:0010369 | chromocenter(GO:0010369) |
5.0 | 19.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
5.0 | 24.8 | GO:0031143 | pseudopodium(GO:0031143) |
5.0 | 9.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
4.9 | 39.5 | GO:0042587 | glycogen granule(GO:0042587) |
4.9 | 24.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
4.9 | 14.7 | GO:0042627 | chylomicron(GO:0042627) |
4.9 | 14.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
4.9 | 29.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
4.9 | 19.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
4.9 | 58.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
4.8 | 29.1 | GO:0005818 | aster(GO:0005818) |
4.8 | 4.8 | GO:0044327 | dendritic spine head(GO:0044327) |
4.8 | 23.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
4.8 | 28.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
4.8 | 4.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
4.7 | 42.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
4.7 | 14.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
4.7 | 23.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
4.7 | 4.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
4.7 | 102.7 | GO:0012505 | endomembrane system(GO:0012505) |
4.7 | 14.0 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
4.7 | 97.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
4.7 | 60.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
4.6 | 9.2 | GO:1990923 | PET complex(GO:1990923) |
4.6 | 13.8 | GO:0005642 | annulate lamellae(GO:0005642) |
4.6 | 27.5 | GO:0016600 | flotillin complex(GO:0016600) |
4.6 | 13.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
4.6 | 22.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
4.6 | 251.9 | GO:0016363 | nuclear matrix(GO:0016363) |
4.6 | 13.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
4.6 | 31.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
4.5 | 13.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
4.5 | 63.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
4.5 | 4.5 | GO:0033270 | paranode region of axon(GO:0033270) |
4.5 | 45.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
4.5 | 13.4 | GO:0071953 | elastic fiber(GO:0071953) |
4.5 | 13.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
4.5 | 22.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
4.5 | 22.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
4.4 | 26.6 | GO:0043219 | lateral loop(GO:0043219) |
4.4 | 93.0 | GO:0000786 | nucleosome(GO:0000786) |
4.4 | 8.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
4.4 | 70.6 | GO:0000145 | exocyst(GO:0000145) |
4.4 | 52.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
4.4 | 39.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
4.4 | 26.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
4.3 | 1041.8 | GO:0030055 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
4.3 | 12.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
4.3 | 17.2 | GO:0030689 | Noc complex(GO:0030689) |
4.3 | 17.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
4.3 | 80.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
4.2 | 17.0 | GO:0005796 | Golgi lumen(GO:0005796) |
4.2 | 220.0 | GO:0016605 | PML body(GO:0016605) |
4.2 | 16.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
4.2 | 12.6 | GO:0070938 | contractile ring(GO:0070938) |
4.2 | 37.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
4.2 | 20.9 | GO:0090543 | Flemming body(GO:0090543) |
4.2 | 12.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
4.1 | 8.3 | GO:0016939 | kinesin II complex(GO:0016939) |
4.1 | 8.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
4.1 | 165.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
4.1 | 4.1 | GO:0005652 | nuclear lamina(GO:0005652) |
4.1 | 53.3 | GO:0005682 | U5 snRNP(GO:0005682) |
4.1 | 8.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
4.1 | 89.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
4.1 | 308.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
4.0 | 40.5 | GO:0070852 | cell body fiber(GO:0070852) |
4.0 | 137.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
4.0 | 68.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
4.0 | 59.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
3.9 | 15.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
3.9 | 27.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
3.9 | 71.0 | GO:0034451 | centriolar satellite(GO:0034451) |
3.9 | 27.4 | GO:0090544 | BAF-type complex(GO:0090544) |
3.9 | 101.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
3.9 | 31.3 | GO:0044440 | endosomal part(GO:0044440) |
3.9 | 330.1 | GO:0005903 | brush border(GO:0005903) |
3.9 | 11.6 | GO:0043293 | apoptosome(GO:0043293) |
3.9 | 15.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
3.8 | 11.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
3.8 | 15.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
3.8 | 11.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
3.8 | 3.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
3.8 | 34.2 | GO:0005869 | dynactin complex(GO:0005869) |
3.8 | 22.7 | GO:0031415 | NatA complex(GO:0031415) |
3.8 | 11.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
3.8 | 11.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
3.8 | 7.5 | GO:0098536 | deuterosome(GO:0098536) |
3.8 | 15.1 | GO:0032009 | early phagosome(GO:0032009) |
3.8 | 30.1 | GO:0055037 | recycling endosome(GO:0055037) |
3.7 | 15.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
3.7 | 15.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
3.7 | 33.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
3.7 | 18.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
3.7 | 22.3 | GO:0042599 | lamellar body(GO:0042599) |
3.7 | 14.8 | GO:0000938 | GARP complex(GO:0000938) |
3.7 | 7.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
3.7 | 3.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
3.7 | 25.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
3.7 | 40.3 | GO:0097225 | sperm midpiece(GO:0097225) |
3.7 | 11.0 | GO:0033269 | internode region of axon(GO:0033269) |
3.6 | 47.4 | GO:0005844 | polysome(GO:0005844) |
3.6 | 10.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
3.6 | 32.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
3.6 | 28.8 | GO:0043196 | varicosity(GO:0043196) |
3.6 | 93.3 | GO:0016592 | mediator complex(GO:0016592) |
3.6 | 50.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
3.6 | 21.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
3.6 | 28.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
3.6 | 28.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
3.5 | 49.7 | GO:0031519 | PcG protein complex(GO:0031519) |
3.5 | 14.2 | GO:0005827 | polar microtubule(GO:0005827) |
3.5 | 10.6 | GO:0005683 | U7 snRNP(GO:0005683) |
3.5 | 77.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
3.5 | 77.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
3.5 | 31.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
3.5 | 10.5 | GO:0071817 | MMXD complex(GO:0071817) |
3.5 | 121.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
3.5 | 10.4 | GO:0005915 | zonula adherens(GO:0005915) |
3.5 | 141.6 | GO:0000922 | spindle pole(GO:0000922) |
3.4 | 6.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
3.4 | 10.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
3.4 | 174.4 | GO:0000502 | proteasome complex(GO:0000502) |
3.4 | 20.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
3.4 | 27.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
3.4 | 10.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.4 | 13.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
3.4 | 6.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
3.4 | 23.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
3.3 | 33.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
3.3 | 132.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
3.3 | 72.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
3.3 | 161.5 | GO:0030496 | midbody(GO:0030496) |
3.3 | 3.3 | GO:0035061 | interchromatin granule(GO:0035061) |
3.3 | 29.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
3.3 | 13.1 | GO:0042629 | mast cell granule(GO:0042629) |
3.3 | 29.4 | GO:0030904 | retromer complex(GO:0030904) |
3.3 | 26.1 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
3.3 | 32.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
3.2 | 58.4 | GO:0005876 | spindle microtubule(GO:0005876) |
3.2 | 113.1 | GO:0005643 | nuclear pore(GO:0005643) |
3.2 | 128.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
3.2 | 54.6 | GO:0001772 | immunological synapse(GO:0001772) |
3.2 | 9.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
3.2 | 6.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
3.2 | 9.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
3.2 | 623.3 | GO:0005667 | transcription factor complex(GO:0005667) |
3.2 | 19.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
3.2 | 9.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
3.1 | 65.9 | GO:0005771 | multivesicular body(GO:0005771) |
3.1 | 9.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
3.1 | 3.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
3.1 | 6.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
3.1 | 99.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
3.1 | 3.1 | GO:0071203 | WASH complex(GO:0071203) |
3.1 | 3.1 | GO:0061574 | ASAP complex(GO:0061574) |
3.1 | 9.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
3.0 | 336.8 | GO:0031965 | nuclear membrane(GO:0031965) |
3.0 | 27.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
3.0 | 84.6 | GO:0005776 | autophagosome(GO:0005776) |
3.0 | 9.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
3.0 | 51.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
3.0 | 9.0 | GO:0046930 | pore complex(GO:0046930) |
3.0 | 14.8 | GO:0097422 | tubular endosome(GO:0097422) |
3.0 | 23.6 | GO:0036379 | myofilament(GO:0036379) |
2.9 | 5.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
2.9 | 5.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
2.9 | 5.8 | GO:0097542 | ciliary tip(GO:0097542) |
2.9 | 11.6 | GO:0034709 | methylosome(GO:0034709) |
2.9 | 17.4 | GO:0042581 | specific granule(GO:0042581) |
2.9 | 23.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
2.8 | 17.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.8 | 17.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
2.8 | 19.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.8 | 62.3 | GO:0016459 | myosin complex(GO:0016459) |
2.8 | 11.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
2.8 | 87.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
2.8 | 5.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
2.8 | 28.1 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
2.8 | 16.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.8 | 289.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
2.7 | 46.7 | GO:0045178 | basal part of cell(GO:0045178) |
2.7 | 62.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
2.7 | 24.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
2.7 | 275.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
2.7 | 48.7 | GO:0097228 | sperm principal piece(GO:0097228) |
2.7 | 2.7 | GO:0001652 | granular component(GO:0001652) |
2.7 | 66.7 | GO:0045171 | intercellular bridge(GO:0045171) |
2.7 | 21.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
2.7 | 2916.5 | GO:0005654 | nucleoplasm(GO:0005654) |
2.7 | 5.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
2.6 | 2.6 | GO:0042827 | platelet dense granule(GO:0042827) |
2.6 | 2.6 | GO:0071797 | LUBAC complex(GO:0071797) |
2.6 | 144.0 | GO:0001726 | ruffle(GO:0001726) |
2.6 | 10.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
2.5 | 2.5 | GO:0070545 | PeBoW complex(GO:0070545) |
2.5 | 7.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
2.5 | 7.6 | GO:0031417 | NatC complex(GO:0031417) |
2.5 | 17.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.5 | 5.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
2.5 | 672.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
2.4 | 4.9 | GO:0097255 | R2TP complex(GO:0097255) |
2.4 | 22.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
2.4 | 78.1 | GO:0000776 | kinetochore(GO:0000776) |
2.4 | 7.1 | GO:0000243 | commitment complex(GO:0000243) |
2.4 | 460.1 | GO:0005694 | chromosome(GO:0005694) |
2.4 | 7.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
2.4 | 4.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
2.3 | 32.6 | GO:0030120 | vesicle coat(GO:0030120) |
2.3 | 3345.5 | GO:0070062 | extracellular exosome(GO:0070062) |
2.3 | 2.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
2.3 | 6.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
2.2 | 33.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
2.2 | 2.2 | GO:0071437 | invadopodium(GO:0071437) |
2.2 | 84.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
2.2 | 6.6 | GO:0043197 | dendritic spine(GO:0043197) |
2.1 | 2.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
2.1 | 52.9 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
2.1 | 2.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.1 | 6.2 | GO:0089701 | U2AF(GO:0089701) |
2.1 | 2.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
2.0 | 2.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
2.0 | 48.4 | GO:0005938 | cell cortex(GO:0005938) |
2.0 | 2.0 | GO:0016342 | catenin complex(GO:0016342) |
2.0 | 162.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
2.0 | 1120.6 | GO:0005829 | cytosol(GO:0005829) |
1.9 | 7.8 | GO:0070652 | HAUS complex(GO:0070652) |
1.9 | 3.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.9 | 7.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
1.9 | 3.9 | GO:1990391 | DNA repair complex(GO:1990391) |
1.9 | 7.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.9 | 3.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.9 | 407.0 | GO:0005730 | nucleolus(GO:0005730) |
1.9 | 31.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.8 | 12.6 | GO:0005902 | microvillus(GO:0005902) |
1.8 | 3.6 | GO:0070069 | cytochrome complex(GO:0070069) |
1.8 | 8.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.8 | 7.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
1.8 | 31.6 | GO:0005901 | caveola(GO:0005901) |
1.7 | 3.4 | GO:0005871 | kinesin complex(GO:0005871) |
1.7 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.7 | 889.3 | GO:0005739 | mitochondrion(GO:0005739) |
1.7 | 33.7 | GO:0005635 | nuclear envelope(GO:0005635) |
1.7 | 11.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.6 | 3.3 | GO:0032584 | growth cone membrane(GO:0032584) |
1.6 | 6.4 | GO:0031512 | motile primary cilium(GO:0031512) |
1.6 | 1.6 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
1.6 | 35.0 | GO:0005795 | Golgi stack(GO:0005795) |
1.6 | 3.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.5 | 75.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
1.5 | 4.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
1.5 | 4.5 | GO:0072372 | primary cilium(GO:0072372) |
1.5 | 29.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.5 | 20.7 | GO:0036126 | sperm flagellum(GO:0036126) |
1.5 | 4.4 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
1.5 | 76.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.5 | 1.5 | GO:0031975 | envelope(GO:0031975) |
1.5 | 27.8 | GO:0045095 | keratin filament(GO:0045095) |
1.4 | 206.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
1.4 | 27.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
1.4 | 34.3 | GO:0031514 | motile cilium(GO:0031514) |
1.4 | 2.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.4 | 797.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
1.4 | 5.4 | GO:0016272 | prefoldin complex(GO:0016272) |
1.3 | 10.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.3 | 2.7 | GO:0030008 | TRAPP complex(GO:0030008) |
1.3 | 3.9 | GO:0005770 | late endosome(GO:0005770) |
1.3 | 5.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.2 | 13.3 | GO:0005614 | interstitial matrix(GO:0005614) |
1.2 | 6.0 | GO:0036157 | outer dynein arm(GO:0036157) |
1.2 | 7.2 | GO:0043218 | compact myelin(GO:0043218) |
1.2 | 4.8 | GO:0032426 | stereocilium tip(GO:0032426) |
1.2 | 7.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
1.2 | 37.5 | GO:0098791 | Golgi subcompartment(GO:0098791) |
1.2 | 3.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.2 | 32.4 | GO:0043292 | contractile fiber(GO:0043292) |
1.1 | 2.3 | GO:0072687 | meiotic spindle(GO:0072687) |
1.1 | 153.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.1 | 5.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
1.1 | 46.0 | GO:0005581 | collagen trimer(GO:0005581) |
1.1 | 2.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.0 | 2.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.0 | 3.0 | GO:0030027 | lamellipodium(GO:0030027) |
1.0 | 1550.4 | GO:0005634 | nucleus(GO:0005634) |
0.9 | 13.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.9 | 38.9 | GO:0005769 | early endosome(GO:0005769) |
0.8 | 81.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.8 | 16.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.7 | 29.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.7 | 10.8 | GO:0005922 | connexon complex(GO:0005922) |
0.6 | 7.0 | GO:0009986 | cell surface(GO:0009986) |
0.6 | 26.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 10.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.5 | 243.6 | GO:0005615 | extracellular space(GO:0005615) |
0.4 | 224.3 | GO:0005576 | extracellular region(GO:0005576) |
0.3 | 1.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 2.3 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.7 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 148.2 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 130.3 | GO:0016021 | integral component of membrane(GO:0016021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.2 | 128.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
24.3 | 170.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
21.4 | 42.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
20.9 | 62.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
20.8 | 104.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
20.5 | 82.0 | GO:0009374 | biotin binding(GO:0009374) |
20.0 | 59.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
19.6 | 58.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
18.9 | 75.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
18.7 | 56.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
18.3 | 54.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
17.6 | 52.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
17.5 | 104.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
16.7 | 66.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
16.4 | 65.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
16.2 | 129.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
14.8 | 59.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
14.7 | 44.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
14.3 | 57.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
13.8 | 13.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
13.7 | 41.1 | GO:0030172 | troponin C binding(GO:0030172) |
13.7 | 13.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
13.3 | 13.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
13.1 | 156.8 | GO:0017166 | vinculin binding(GO:0017166) |
13.1 | 39.2 | GO:0050692 | DBD domain binding(GO:0050692) |
12.9 | 51.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
12.5 | 25.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
12.5 | 37.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
12.3 | 37.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
12.3 | 49.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
11.9 | 23.8 | GO:0070538 | oleic acid binding(GO:0070538) |
11.9 | 35.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
11.8 | 47.3 | GO:0015232 | heme transporter activity(GO:0015232) |
11.7 | 35.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
11.6 | 46.3 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
11.6 | 11.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
11.5 | 69.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
11.5 | 57.5 | GO:0030274 | LIM domain binding(GO:0030274) |
11.4 | 45.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
11.4 | 45.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
11.3 | 22.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
11.2 | 33.6 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
11.0 | 33.0 | GO:0031014 | troponin T binding(GO:0031014) |
10.9 | 152.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
10.8 | 32.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
10.7 | 75.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
10.7 | 32.1 | GO:0004064 | arylesterase activity(GO:0004064) |
10.6 | 42.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
10.6 | 201.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
10.6 | 31.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
10.5 | 41.9 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
10.4 | 41.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
10.4 | 31.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
10.4 | 62.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
10.3 | 41.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
10.3 | 30.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
10.2 | 82.0 | GO:0008430 | selenium binding(GO:0008430) |
10.2 | 30.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
10.2 | 50.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
10.2 | 61.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
10.1 | 40.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
10.1 | 80.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
10.0 | 20.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
10.0 | 10.0 | GO:0034618 | arginine binding(GO:0034618) |
10.0 | 109.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
9.9 | 29.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
9.9 | 19.8 | GO:0031013 | troponin I binding(GO:0031013) |
9.9 | 19.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
9.8 | 59.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
9.8 | 29.5 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
9.8 | 19.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
9.8 | 39.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
9.8 | 29.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
9.8 | 9.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
9.7 | 87.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
9.7 | 48.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
9.5 | 76.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
9.4 | 47.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
9.4 | 56.2 | GO:0008199 | ferric iron binding(GO:0008199) |
9.3 | 18.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
9.3 | 28.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
9.3 | 27.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
9.2 | 27.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
9.2 | 73.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
9.2 | 27.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
9.2 | 109.9 | GO:0044548 | S100 protein binding(GO:0044548) |
9.1 | 36.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
9.0 | 45.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
9.0 | 81.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
9.0 | 17.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
9.0 | 17.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
8.9 | 62.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
8.9 | 26.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
8.9 | 88.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
8.8 | 35.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
8.8 | 53.0 | GO:0031432 | titin binding(GO:0031432) |
8.8 | 35.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
8.8 | 35.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
8.8 | 123.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
8.7 | 34.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
8.6 | 77.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
8.6 | 34.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
8.6 | 34.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
8.5 | 76.8 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
8.5 | 8.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
8.5 | 59.2 | GO:0018653 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
8.3 | 33.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
8.3 | 91.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
8.3 | 16.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
8.3 | 8.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
8.2 | 24.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
8.2 | 32.7 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
8.1 | 73.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
8.0 | 40.1 | GO:0015288 | porin activity(GO:0015288) |
8.0 | 24.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
8.0 | 40.0 | GO:0070061 | fructose binding(GO:0070061) |
8.0 | 71.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
8.0 | 95.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
7.9 | 23.8 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
7.9 | 31.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
7.9 | 86.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
7.8 | 39.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
7.8 | 47.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
7.8 | 31.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
7.8 | 23.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
7.8 | 15.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
7.7 | 61.9 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
7.7 | 38.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
7.7 | 107.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
7.7 | 84.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
7.6 | 7.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
7.6 | 45.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
7.6 | 30.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
7.6 | 121.0 | GO:0008143 | poly(A) binding(GO:0008143) |
7.5 | 15.1 | GO:0015250 | water channel activity(GO:0015250) |
7.5 | 30.1 | GO:0005534 | galactose binding(GO:0005534) |
7.5 | 97.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
7.5 | 22.5 | GO:0008142 | oxysterol binding(GO:0008142) |
7.5 | 30.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
7.4 | 14.9 | GO:0015928 | fucosidase activity(GO:0015928) |
7.4 | 29.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
7.4 | 22.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
7.3 | 22.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
7.3 | 21.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
7.3 | 21.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
7.3 | 159.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
7.3 | 21.8 | GO:0019961 | interferon binding(GO:0019961) |
7.3 | 14.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
7.2 | 137.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
7.2 | 7.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
7.2 | 64.7 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
7.1 | 7.1 | GO:0019808 | polyamine binding(GO:0019808) |
7.1 | 21.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
7.1 | 14.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
7.1 | 35.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
7.1 | 56.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
7.1 | 63.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
7.0 | 63.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
7.0 | 105.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
7.0 | 21.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
7.0 | 28.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
7.0 | 76.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
7.0 | 21.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
6.9 | 27.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
6.9 | 20.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
6.9 | 20.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
6.9 | 13.7 | GO:0035877 | death effector domain binding(GO:0035877) |
6.9 | 13.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
6.8 | 34.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
6.8 | 40.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
6.8 | 102.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
6.8 | 20.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
6.8 | 33.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
6.7 | 6.7 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
6.7 | 26.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
6.7 | 59.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
6.6 | 33.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
6.6 | 13.3 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
6.6 | 13.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
6.6 | 13.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
6.6 | 19.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
6.6 | 26.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
6.5 | 65.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
6.5 | 32.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
6.5 | 19.6 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
6.5 | 19.5 | GO:0055100 | adiponectin binding(GO:0055100) |
6.5 | 12.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
6.5 | 12.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
6.5 | 19.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
6.4 | 19.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
6.4 | 19.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
6.4 | 25.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
6.4 | 32.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
6.4 | 12.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
6.4 | 19.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
6.4 | 31.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
6.3 | 57.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
6.3 | 38.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
6.3 | 38.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
6.3 | 88.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
6.3 | 25.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
6.3 | 25.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
6.3 | 6.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
6.3 | 25.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
6.3 | 25.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
6.3 | 56.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
6.2 | 6.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
6.2 | 6.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
6.1 | 67.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
6.1 | 116.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
6.1 | 73.0 | GO:0005542 | folic acid binding(GO:0005542) |
6.0 | 42.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
6.0 | 24.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
6.0 | 6.0 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
6.0 | 36.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
6.0 | 12.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
6.0 | 12.0 | GO:0043559 | insulin binding(GO:0043559) |
6.0 | 12.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
6.0 | 41.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
5.9 | 29.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
5.9 | 5.9 | GO:0048030 | disaccharide binding(GO:0048030) |
5.9 | 5.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
5.9 | 23.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
5.8 | 29.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
5.8 | 23.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
5.8 | 5.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
5.8 | 23.1 | GO:0043515 | kinetochore binding(GO:0043515) |
5.8 | 17.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
5.8 | 17.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
5.7 | 23.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
5.7 | 17.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
5.7 | 165.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
5.6 | 16.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
5.6 | 33.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
5.6 | 5.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
5.6 | 55.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
5.6 | 11.2 | GO:0016208 | AMP binding(GO:0016208) |
5.6 | 50.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
5.6 | 22.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
5.6 | 22.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
5.5 | 16.6 | GO:0042731 | PH domain binding(GO:0042731) |
5.5 | 115.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
5.5 | 160.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
5.5 | 16.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
5.5 | 11.0 | GO:0030519 | snoRNP binding(GO:0030519) |
5.5 | 33.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
5.5 | 44.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
5.5 | 16.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
5.5 | 21.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
5.5 | 21.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
5.5 | 43.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
5.4 | 10.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
5.4 | 5.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
5.4 | 21.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
5.4 | 97.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
5.4 | 5.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
5.4 | 10.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
5.4 | 10.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
5.4 | 91.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
5.4 | 21.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
5.4 | 21.5 | GO:0034549 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
5.4 | 16.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
5.4 | 32.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
5.3 | 26.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
5.3 | 37.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
5.3 | 21.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
5.3 | 80.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
5.3 | 5.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
5.3 | 133.1 | GO:0043236 | laminin binding(GO:0043236) |
5.3 | 26.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
5.3 | 15.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
5.3 | 26.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
5.3 | 21.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
5.3 | 26.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
5.3 | 73.5 | GO:0005521 | lamin binding(GO:0005521) |
5.2 | 21.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
5.2 | 10.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
5.2 | 47.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
5.2 | 130.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
5.2 | 5.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
5.2 | 26.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
5.2 | 88.5 | GO:0008483 | transaminase activity(GO:0008483) |
5.2 | 5.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
5.2 | 26.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
5.2 | 5.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
5.2 | 31.1 | GO:0019825 | oxygen binding(GO:0019825) |
5.2 | 20.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
5.2 | 51.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
5.1 | 15.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
5.1 | 5.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
5.1 | 25.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
5.1 | 20.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
5.1 | 25.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
5.1 | 15.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
5.1 | 15.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
5.1 | 45.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
5.1 | 10.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
5.1 | 81.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
5.1 | 35.4 | GO:0046790 | virion binding(GO:0046790) |
5.1 | 20.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
5.1 | 15.2 | GO:0034452 | dynactin binding(GO:0034452) |
5.1 | 30.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
5.1 | 20.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
5.0 | 50.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
5.0 | 10.1 | GO:0038132 | neuregulin binding(GO:0038132) |
5.0 | 45.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
5.0 | 5.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
5.0 | 25.1 | GO:0034046 | poly(G) binding(GO:0034046) |
5.0 | 120.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
5.0 | 29.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
5.0 | 19.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
5.0 | 19.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
4.9 | 59.2 | GO:0010181 | FMN binding(GO:0010181) |
4.9 | 19.7 | GO:0030984 | kininogen binding(GO:0030984) |
4.9 | 19.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
4.9 | 39.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
4.9 | 39.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
4.9 | 44.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
4.9 | 9.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
4.9 | 24.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
4.8 | 43.6 | GO:0005123 | death receptor binding(GO:0005123) |
4.8 | 82.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
4.8 | 62.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
4.8 | 14.4 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
4.8 | 81.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
4.8 | 86.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
4.8 | 23.9 | GO:0005536 | glucose binding(GO:0005536) |
4.8 | 14.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
4.8 | 4.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
4.8 | 19.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
4.8 | 19.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
4.8 | 42.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
4.8 | 28.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
4.7 | 9.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
4.7 | 9.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
4.7 | 14.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
4.7 | 23.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
4.7 | 51.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
4.7 | 14.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
4.7 | 9.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
4.7 | 47.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
4.7 | 23.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
4.7 | 37.5 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
4.7 | 46.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
4.7 | 23.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
4.7 | 51.5 | GO:0032183 | SUMO binding(GO:0032183) |
4.7 | 9.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
4.7 | 9.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
4.7 | 4.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
4.7 | 14.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
4.7 | 14.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
4.7 | 32.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
4.6 | 32.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
4.6 | 18.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
4.6 | 13.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
4.6 | 59.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
4.6 | 13.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
4.6 | 13.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
4.6 | 36.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
4.6 | 9.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
4.6 | 27.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
4.6 | 68.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
4.5 | 31.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
4.5 | 4.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
4.5 | 49.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
4.5 | 13.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
4.5 | 13.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
4.5 | 22.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
4.5 | 4.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
4.5 | 98.9 | GO:0045502 | dynein binding(GO:0045502) |
4.5 | 13.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
4.5 | 9.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
4.5 | 49.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
4.4 | 8.9 | GO:0031404 | chloride ion binding(GO:0031404) |
4.4 | 4.4 | GO:0002054 | nucleobase binding(GO:0002054) |
4.4 | 13.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
4.4 | 8.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
4.4 | 26.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
4.4 | 17.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
4.4 | 30.9 | GO:0018855 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
4.4 | 22.0 | GO:0005499 | vitamin D binding(GO:0005499) |
4.4 | 17.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
4.3 | 60.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
4.3 | 13.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
4.3 | 21.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
4.3 | 8.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
4.2 | 8.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
4.2 | 21.2 | GO:0008494 | translation activator activity(GO:0008494) |
4.2 | 38.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
4.2 | 25.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
4.2 | 12.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
4.2 | 38.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
4.2 | 76.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
4.2 | 12.6 | GO:0080084 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
4.2 | 8.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
4.2 | 16.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
4.2 | 25.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
4.2 | 29.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
4.2 | 4.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.2 | 16.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
4.2 | 16.8 | GO:0003680 | AT DNA binding(GO:0003680) |
4.2 | 29.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
4.2 | 37.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
4.2 | 49.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
4.1 | 33.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
4.1 | 12.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
4.1 | 37.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
4.1 | 24.7 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
4.1 | 37.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
4.1 | 41.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
4.1 | 24.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
4.1 | 16.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
4.1 | 49.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
4.1 | 32.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
4.0 | 4.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
4.0 | 16.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
4.0 | 4.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
4.0 | 40.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
4.0 | 16.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
4.0 | 24.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
4.0 | 4.0 | GO:1904680 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
4.0 | 27.9 | GO:0001846 | opsonin binding(GO:0001846) |
4.0 | 91.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
4.0 | 8.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
4.0 | 55.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
4.0 | 31.8 | GO:0031996 | thioesterase binding(GO:0031996) |
4.0 | 11.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
4.0 | 15.9 | GO:0031419 | cobalamin binding(GO:0031419) |
4.0 | 15.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
3.9 | 15.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
3.9 | 11.8 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
3.9 | 11.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.9 | 23.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
3.9 | 46.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
3.9 | 144.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
3.9 | 15.6 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
3.9 | 11.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
3.9 | 120.8 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
3.9 | 299.5 | GO:0002020 | protease binding(GO:0002020) |
3.9 | 23.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
3.9 | 19.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
3.9 | 50.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
3.9 | 34.8 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
3.9 | 23.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
3.8 | 26.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
3.8 | 11.5 | GO:0019862 | IgA binding(GO:0019862) |
3.8 | 68.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
3.8 | 15.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
3.8 | 11.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
3.8 | 3.8 | GO:0004518 | nuclease activity(GO:0004518) |
3.8 | 3.8 | GO:0004096 | catalase activity(GO:0004096) |
3.7 | 33.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
3.7 | 37.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
3.7 | 89.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
3.7 | 18.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
3.7 | 63.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
3.7 | 11.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
3.7 | 7.4 | GO:1990188 | euchromatin binding(GO:1990188) |
3.7 | 44.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
3.7 | 11.1 | GO:0071253 | connexin binding(GO:0071253) |
3.7 | 25.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
3.7 | 11.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
3.7 | 36.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
3.7 | 14.7 | GO:0031491 | nucleosome binding(GO:0031491) |
3.7 | 29.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
3.7 | 18.3 | GO:0050700 | CARD domain binding(GO:0050700) |
3.7 | 153.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
3.7 | 69.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
3.6 | 7.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
3.6 | 40.1 | GO:0015643 | toxic substance binding(GO:0015643) |
3.6 | 116.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
3.6 | 10.9 | GO:0000182 | rDNA binding(GO:0000182) |
3.6 | 21.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
3.6 | 7.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
3.6 | 72.4 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
3.6 | 10.9 | GO:0004359 | glutaminase activity(GO:0004359) |
3.6 | 10.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
3.6 | 169.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
3.6 | 326.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
3.6 | 7.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
3.6 | 110.8 | GO:0051723 | protein methylesterase activity(GO:0051723) |
3.6 | 10.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
3.6 | 156.7 | GO:0035326 | enhancer binding(GO:0035326) |
3.6 | 17.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
3.6 | 60.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
3.5 | 74.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
3.5 | 10.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
3.5 | 24.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
3.5 | 21.1 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
3.5 | 21.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
3.5 | 3.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
3.5 | 129.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
3.5 | 14.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
3.5 | 24.4 | GO:0070402 | NADPH binding(GO:0070402) |
3.5 | 59.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
3.5 | 55.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
3.5 | 76.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
3.4 | 17.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
3.4 | 6.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
3.4 | 3.4 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
3.4 | 10.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
3.4 | 6.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
3.4 | 30.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
3.4 | 201.2 | GO:0005178 | integrin binding(GO:0005178) |
3.4 | 10.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
3.4 | 10.2 | GO:0019002 | GMP binding(GO:0019002) |
3.4 | 3.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
3.4 | 13.5 | GO:0043274 | phospholipase binding(GO:0043274) |
3.4 | 23.7 | GO:0001848 | complement binding(GO:0001848) |
3.4 | 23.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
3.4 | 279.1 | GO:0042393 | histone binding(GO:0042393) |
3.4 | 50.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
3.3 | 6.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
3.3 | 3.3 | GO:0043426 | MRF binding(GO:0043426) |
3.3 | 13.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
3.3 | 23.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
3.3 | 19.8 | GO:0050733 | RS domain binding(GO:0050733) |
3.3 | 19.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
3.3 | 36.3 | GO:0060590 | ATPase activator activity(GO:0001671) ATPase regulator activity(GO:0060590) |
3.3 | 82.2 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
3.3 | 6.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
3.3 | 6.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
3.3 | 3.3 | GO:0015923 | mannosidase activity(GO:0015923) |
3.2 | 25.9 | GO:0001618 | virus receptor activity(GO:0001618) |
3.2 | 19.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
3.2 | 3.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
3.2 | 19.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
3.2 | 60.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
3.2 | 16.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
3.2 | 9.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
3.2 | 25.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
3.2 | 3.2 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
3.2 | 22.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
3.1 | 6.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
3.1 | 18.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
3.1 | 3.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
3.1 | 18.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
3.1 | 3.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
3.1 | 12.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
3.1 | 9.4 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
3.1 | 18.7 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
3.1 | 15.6 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
3.1 | 401.6 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
3.1 | 6.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
3.1 | 15.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
3.1 | 3.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
3.1 | 89.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
3.1 | 6.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
3.1 | 6.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
3.1 | 3.1 | GO:0070728 | leucine binding(GO:0070728) |
3.1 | 92.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
3.1 | 9.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
3.1 | 9.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
3.1 | 33.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
3.1 | 12.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
3.1 | 9.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
3.0 | 91.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
3.0 | 94.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
3.0 | 9.1 | GO:0035671 | enone reductase activity(GO:0035671) |
3.0 | 63.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
3.0 | 69.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
3.0 | 11.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
3.0 | 59.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
3.0 | 59.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
3.0 | 5.9 | GO:0019213 | deacetylase activity(GO:0019213) |
3.0 | 62.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
3.0 | 3.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
3.0 | 204.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
3.0 | 23.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
2.9 | 26.5 | GO:0004568 | chitinase activity(GO:0004568) |
2.9 | 11.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
2.9 | 5.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
2.9 | 14.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
2.9 | 26.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.9 | 102.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
2.9 | 52.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
2.9 | 2.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
2.9 | 64.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
2.9 | 20.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
2.9 | 5.8 | GO:0043495 | protein anchor(GO:0043495) |
2.9 | 141.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
2.9 | 112.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
2.9 | 94.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
2.9 | 8.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.9 | 11.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
2.9 | 5.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
2.8 | 11.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.8 | 2.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.8 | 8.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
2.8 | 264.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
2.8 | 2.8 | GO:0036122 | BMP binding(GO:0036122) |
2.8 | 19.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
2.8 | 22.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.8 | 11.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
2.8 | 25.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
2.8 | 72.0 | GO:0005507 | copper ion binding(GO:0005507) |
2.8 | 2.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
2.7 | 11.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
2.7 | 76.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
2.7 | 8.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
2.7 | 193.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
2.7 | 13.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
2.7 | 16.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
2.7 | 24.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
2.7 | 2.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
2.7 | 18.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.7 | 2.7 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
2.7 | 67.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
2.7 | 8.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
2.7 | 37.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.7 | 34.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
2.7 | 179.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
2.7 | 10.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
2.7 | 8.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
2.7 | 13.3 | GO:0070628 | proteasome binding(GO:0070628) |
2.7 | 31.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
2.6 | 457.6 | GO:0008134 | transcription factor binding(GO:0008134) |
2.6 | 7.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
2.6 | 13.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.6 | 86.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
2.6 | 10.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
2.6 | 23.5 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
2.6 | 23.4 | GO:0015605 | nucleotide transmembrane transporter activity(GO:0015215) organophosphate ester transmembrane transporter activity(GO:0015605) |
2.6 | 7.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.6 | 10.4 | GO:0034584 | piRNA binding(GO:0034584) |
2.6 | 10.4 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
2.6 | 7.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
2.6 | 49.1 | GO:0043621 | protein self-association(GO:0043621) |
2.6 | 25.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
2.5 | 25.4 | GO:0003785 | actin monomer binding(GO:0003785) |
2.5 | 2.5 | GO:0016015 | morphogen activity(GO:0016015) |
2.5 | 12.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
2.5 | 7.5 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.5 | 5.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.5 | 2.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.5 | 7.5 | GO:0038100 | nodal binding(GO:0038100) |
2.5 | 12.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.5 | 7.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
2.4 | 12.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
2.4 | 2.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
2.4 | 12.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
2.4 | 28.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.4 | 23.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
2.4 | 9.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
2.4 | 128.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
2.4 | 7.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
2.3 | 65.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
2.3 | 7.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
2.3 | 4.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
2.3 | 13.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.3 | 4.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
2.3 | 11.5 | GO:1990405 | protein antigen binding(GO:1990405) |
2.3 | 11.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
2.3 | 9.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
2.3 | 55.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
2.3 | 6.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.3 | 96.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
2.3 | 77.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
2.3 | 9.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
2.3 | 90.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
2.3 | 2.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
2.3 | 4.5 | GO:2001070 | starch binding(GO:2001070) |
2.3 | 2.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
2.2 | 11.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.2 | 2.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
2.2 | 13.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
2.2 | 17.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.2 | 269.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
2.2 | 6.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
2.2 | 6.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
2.2 | 6.5 | GO:0034062 | RNA polymerase activity(GO:0034062) |
2.1 | 49.4 | GO:0015485 | cholesterol binding(GO:0015485) |
2.1 | 25.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
2.1 | 17.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
2.1 | 2.1 | GO:0031433 | telethonin binding(GO:0031433) |
2.1 | 124.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
2.1 | 10.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
2.1 | 40.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
2.1 | 4.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
2.1 | 16.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
2.1 | 8.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
2.1 | 195.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.1 | 58.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.1 | 4.2 | GO:0000339 | RNA cap binding(GO:0000339) |
2.1 | 100.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
2.1 | 4.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.1 | 6.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
2.1 | 6.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.1 | 10.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
2.0 | 6.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
2.0 | 22.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
2.0 | 60.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
2.0 | 16.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
2.0 | 36.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
2.0 | 24.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
2.0 | 10.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
2.0 | 21.9 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
2.0 | 6.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
2.0 | 6.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
2.0 | 4.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.9 | 17.3 | GO:0030515 | snoRNA binding(GO:0030515) |
1.9 | 3.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.9 | 1.9 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
1.9 | 5.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.9 | 3.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.9 | 7.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.9 | 13.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.9 | 9.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.9 | 13.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.9 | 255.0 | GO:0005125 | cytokine activity(GO:0005125) |
1.9 | 16.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.9 | 14.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
1.9 | 1.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.9 | 316.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.9 | 18.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.9 | 40.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
1.9 | 11.1 | GO:0043531 | ADP binding(GO:0043531) |
1.8 | 16.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
1.8 | 9.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.8 | 5.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.8 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
1.8 | 9.1 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
1.8 | 9.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.8 | 1.8 | GO:0008061 | chitin binding(GO:0008061) |
1.8 | 296.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.8 | 12.7 | GO:0030955 | potassium ion binding(GO:0030955) |
1.8 | 421.2 | GO:0005198 | structural molecule activity(GO:0005198) |
1.8 | 9.0 | GO:0005113 | patched binding(GO:0005113) |
1.8 | 10.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.8 | 17.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.8 | 5.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.8 | 17.7 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
1.8 | 3.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.8 | 1.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.8 | 8.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
1.7 | 3.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.7 | 13.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.7 | 19.0 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
1.7 | 10.3 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
1.7 | 5.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.7 | 10.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.7 | 64.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
1.7 | 6.7 | GO:0017016 | Ras GTPase binding(GO:0017016) |
1.7 | 11.7 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
1.7 | 56.6 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
1.7 | 6.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.7 | 1.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
1.6 | 6.6 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.6 | 11.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.6 | 4.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.6 | 182.1 | GO:0003924 | GTPase activity(GO:0003924) |
1.6 | 9.7 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
1.6 | 64.8 | GO:0008565 | protein transporter activity(GO:0008565) |
1.6 | 824.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
1.6 | 6.4 | GO:0039706 | co-receptor binding(GO:0039706) |
1.6 | 4.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.6 | 4.8 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.6 | 4.8 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
1.6 | 12.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
1.6 | 52.8 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
1.5 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
1.5 | 40.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
1.5 | 251.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
1.5 | 3.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
1.5 | 20.6 | GO:0005537 | mannose binding(GO:0005537) |
1.5 | 2.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.5 | 1.5 | GO:0015927 | trehalase activity(GO:0015927) |
1.4 | 5.8 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
1.4 | 8.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.4 | 17.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.4 | 15.7 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
1.4 | 2.8 | GO:0030911 | TPR domain binding(GO:0030911) |
1.4 | 9.9 | GO:0035586 | purinergic receptor activity(GO:0035586) |
1.4 | 7.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.4 | 23.8 | GO:0001047 | core promoter binding(GO:0001047) |
1.4 | 5.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.4 | 1.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.4 | 10.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.4 | 12.2 | GO:0043022 | ribosome binding(GO:0043022) |
1.4 | 9.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
1.4 | 1.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.4 | 2.7 | GO:0035197 | siRNA binding(GO:0035197) |
1.3 | 9.4 | GO:0003796 | lysozyme activity(GO:0003796) |
1.3 | 6.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.3 | 11.9 | GO:0003724 | RNA helicase activity(GO:0003724) |
1.3 | 8.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.3 | 1.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
1.3 | 6.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.3 | 24.6 | GO:0051117 | ATPase binding(GO:0051117) |
1.3 | 20.7 | GO:0005501 | retinoid binding(GO:0005501) |
1.3 | 1.3 | GO:0070840 | dynein complex binding(GO:0070840) |
1.3 | 2.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.3 | 12.6 | GO:0005112 | Notch binding(GO:0005112) |
1.2 | 22.5 | GO:0051087 | chaperone binding(GO:0051087) |
1.2 | 6.2 | GO:0051400 | BH domain binding(GO:0051400) |
1.2 | 19.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.2 | 1.2 | GO:0070052 | collagen V binding(GO:0070052) |
1.2 | 2.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.2 | 49.1 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
1.2 | 1.2 | GO:0019956 | chemokine binding(GO:0019956) |
1.2 | 1.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.2 | 3.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
1.2 | 1.2 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
1.2 | 1.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
1.2 | 1.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.2 | 12.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.1 | 4.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.1 | 22.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
1.1 | 13.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.1 | 5.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.1 | 29.3 | GO:0004519 | endonuclease activity(GO:0004519) |
1.1 | 4.5 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
1.1 | 6.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
1.1 | 27.7 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
1.1 | 12.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.1 | 3.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.1 | 16.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
1.1 | 18.3 | GO:0061134 | peptidase regulator activity(GO:0061134) |
1.1 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.0 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.0 | 1.0 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
1.0 | 113.8 | GO:0005525 | GTP binding(GO:0005525) |
1.0 | 12.3 | GO:0030507 | spectrin binding(GO:0030507) |
1.0 | 4.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.0 | 97.7 | GO:0003779 | actin binding(GO:0003779) |
1.0 | 7.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
1.0 | 63.0 | GO:0003712 | transcription cofactor activity(GO:0003712) |
1.0 | 20.3 | GO:0050699 | WW domain binding(GO:0050699) |
1.0 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.0 | 2.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.0 | 74.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.9 | 8.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.9 | 1.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.9 | 2.8 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.9 | 45.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.9 | 10.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.9 | 27.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.9 | 1.8 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.9 | 15.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.9 | 8.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.8 | 1.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.8 | 9.3 | GO:0042805 | actinin binding(GO:0042805) |
0.8 | 1.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.8 | 1.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.8 | 4.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.8 | 0.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.8 | 3.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.8 | 7.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.8 | 2.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.8 | 34.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.8 | 3.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.8 | 49.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.8 | 3.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.8 | 12.4 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.8 | 6.2 | GO:0005222 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.8 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.8 | 4.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.7 | 1.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.7 | 2.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.7 | 3.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 19.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.7 | 2.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.7 | 4.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.7 | 1.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.7 | 574.8 | GO:0003677 | DNA binding(GO:0003677) |
0.7 | 3.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.7 | 3.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 1.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.7 | 7.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.7 | 12.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.7 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 1.8 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 1.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.6 | 1.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.6 | 17.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.6 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 5.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 2.6 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 2.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.5 | 1.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.5 | 3.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.5 | 107.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.4 | 16.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.4 | 0.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 5.7 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.4 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.4 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 0.8 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.4 | 0.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.4 | 6.6 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.4 | 15.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.4 | 8.4 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.4 | 3.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 1.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 6.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.4 | 0.4 | GO:0070697 | activin receptor binding(GO:0070697) |
0.3 | 3.1 | GO:0051020 | GTPase binding(GO:0051020) |
0.3 | 27.9 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.3 | 4.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 6.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.3 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 0.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.3 | 1.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.3 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 1.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 2.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 216.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 22.6 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.2 | 17.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.2 | 16.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.2 | 3.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 1.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.1 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 2.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.0 | 21.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
11.8 | 106.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
9.8 | 244.7 | PID IGF1 PATHWAY | IGF1 pathway |
9.5 | 238.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
9.5 | 133.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
9.3 | 353.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
9.3 | 120.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
9.0 | 161.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
8.9 | 499.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
8.7 | 8.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
8.7 | 130.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
8.6 | 77.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
8.1 | 72.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
7.9 | 118.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
7.8 | 7.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
7.7 | 92.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
7.6 | 106.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
7.5 | 15.1 | PID IFNG PATHWAY | IFN-gamma pathway |
7.4 | 331.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
7.4 | 250.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
7.3 | 29.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
7.3 | 255.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
7.2 | 101.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
7.2 | 86.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
7.2 | 164.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
7.0 | 14.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
7.0 | 14.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
7.0 | 139.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
6.9 | 159.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
6.9 | 41.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
6.8 | 101.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
6.7 | 53.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
6.6 | 33.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
6.4 | 70.5 | PID EPO PATHWAY | EPO signaling pathway |
6.4 | 293.5 | PID P73PATHWAY | p73 transcription factor network |
6.2 | 6.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
6.1 | 140.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
6.1 | 18.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
5.9 | 304.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
5.8 | 116.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
5.8 | 145.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
5.7 | 158.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
5.6 | 61.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
5.4 | 70.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
5.4 | 166.7 | PID P53 REGULATION PATHWAY | p53 pathway |
5.3 | 73.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
5.2 | 109.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
5.0 | 75.4 | PID AURORA A PATHWAY | Aurora A signaling |
5.0 | 69.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
4.9 | 24.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
4.7 | 9.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
4.7 | 79.1 | PID RHOA PATHWAY | RhoA signaling pathway |
4.6 | 18.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
4.6 | 18.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
4.6 | 50.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
4.6 | 18.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
4.5 | 45.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
4.5 | 18.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
4.5 | 117.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
4.5 | 58.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
4.4 | 31.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
4.4 | 75.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
4.3 | 213.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
4.3 | 8.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
4.2 | 97.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
4.2 | 59.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
4.2 | 50.5 | ST GAQ PATHWAY | G alpha q Pathway |
4.2 | 29.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
4.2 | 12.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
4.1 | 12.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
4.1 | 65.6 | PID ARF6 PATHWAY | Arf6 signaling events |
4.1 | 4.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
4.1 | 4.1 | PID MYC PATHWAY | C-MYC pathway |
4.1 | 57.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
4.1 | 109.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
4.0 | 16.0 | PID FOXO PATHWAY | FoxO family signaling |
4.0 | 55.5 | PID BCR 5PATHWAY | BCR signaling pathway |
3.9 | 63.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
3.9 | 39.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
3.9 | 96.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
3.7 | 227.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
3.6 | 61.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
3.6 | 90.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
3.6 | 65.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
3.6 | 14.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
3.5 | 92.1 | PID PLK1 PATHWAY | PLK1 signaling events |
3.4 | 10.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
3.3 | 19.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
3.3 | 19.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
3.3 | 58.9 | PID AURORA B PATHWAY | Aurora B signaling |
3.1 | 112.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
3.1 | 15.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
3.1 | 3.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
3.1 | 55.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
3.0 | 27.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
3.0 | 42.0 | PID BARD1 PATHWAY | BARD1 signaling events |
2.9 | 14.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
2.9 | 5.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.9 | 37.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
2.9 | 20.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
2.8 | 22.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
2.7 | 27.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
2.6 | 13.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
2.6 | 36.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
2.6 | 28.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
2.6 | 12.8 | PID ATM PATHWAY | ATM pathway |
2.5 | 17.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
2.5 | 35.4 | PID ATR PATHWAY | ATR signaling pathway |
2.5 | 45.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
2.5 | 29.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
2.4 | 21.5 | PID ALK1 PATHWAY | ALK1 signaling events |
2.3 | 25.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.3 | 55.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
2.3 | 20.6 | PID ALK2 PATHWAY | ALK2 signaling events |
2.3 | 4.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
2.3 | 9.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
2.3 | 435.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
2.2 | 2.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
2.2 | 21.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.2 | 38.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
2.1 | 2.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
2.1 | 2.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
2.1 | 16.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
2.0 | 6.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.0 | 31.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
2.0 | 13.9 | PID RAS PATHWAY | Regulation of Ras family activation |
1.9 | 32.8 | PID LKB1 PATHWAY | LKB1 signaling events |
1.9 | 19.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.9 | 34.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.9 | 15.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.9 | 5.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.9 | 39.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.8 | 3.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.8 | 19.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
1.7 | 3.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.7 | 54.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.7 | 5.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.7 | 11.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.6 | 3.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.5 | 15.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.5 | 6.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.5 | 29.8 | PID E2F PATHWAY | E2F transcription factor network |
1.5 | 3.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.5 | 41.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.5 | 10.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.4 | 10.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.4 | 22.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.3 | 14.0 | PID ARF 3PATHWAY | Arf1 pathway |
1.3 | 6.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.3 | 15.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.2 | 166.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.2 | 4.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
1.2 | 3.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.2 | 4.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.2 | 21.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.2 | 9.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.1 | 3.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.1 | 9.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.1 | 29.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.1 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.1 | 3.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.1 | 2.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.1 | 141.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.1 | 8.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.0 | 6.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.0 | 30.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.0 | 11.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.8 | 4.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 5.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.7 | 33.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.7 | 10.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.5 | 2.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 6.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.4 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.4 | 2.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.4 | 1.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 3.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 45.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 1.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 1.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.5 | 216.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
12.7 | 114.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
11.6 | 93.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
11.0 | 121.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
10.7 | 53.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
10.1 | 101.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
10.1 | 171.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
9.9 | 99.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
9.4 | 112.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
9.2 | 18.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
9.2 | 128.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
9.0 | 99.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
8.9 | 98.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
8.9 | 53.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
8.8 | 114.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
8.7 | 78.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
8.7 | 227.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
8.7 | 87.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
8.6 | 25.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
8.4 | 58.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
8.3 | 141.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
8.2 | 123.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
8.1 | 154.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
8.1 | 8.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
8.1 | 209.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
8.0 | 40.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
8.0 | 112.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
8.0 | 8.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
7.9 | 47.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
7.9 | 39.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
7.9 | 142.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
7.9 | 31.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
7.8 | 101.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
7.5 | 74.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
7.4 | 178.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
7.2 | 166.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
7.1 | 71.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
7.1 | 170.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
7.0 | 98.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
7.0 | 209.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
6.9 | 27.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
6.9 | 75.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
6.8 | 182.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
6.7 | 13.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
6.7 | 53.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
6.6 | 59.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
6.5 | 91.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
6.5 | 78.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
6.4 | 45.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
6.4 | 6.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
6.4 | 120.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
6.4 | 38.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
6.3 | 63.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
6.3 | 63.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
6.3 | 68.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
6.2 | 56.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
6.2 | 93.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
6.1 | 61.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
6.1 | 559.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
6.1 | 152.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
6.1 | 91.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
6.1 | 230.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
6.0 | 42.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
6.0 | 137.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
5.9 | 5.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
5.9 | 11.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
5.7 | 51.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
5.7 | 45.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
5.4 | 54.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
5.4 | 10.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
5.4 | 96.7 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
5.4 | 80.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
5.3 | 10.7 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
5.3 | 143.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
5.2 | 57.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
5.2 | 129.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
5.1 | 20.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
5.1 | 50.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
5.0 | 70.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
5.0 | 35.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
5.0 | 267.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
4.8 | 53.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
4.8 | 106.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
4.8 | 52.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
4.7 | 4.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
4.7 | 71.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
4.7 | 61.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
4.6 | 18.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
4.6 | 36.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
4.6 | 255.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
4.6 | 41.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
4.5 | 9.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
4.4 | 115.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
4.3 | 112.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
4.3 | 34.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
4.3 | 38.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
4.3 | 47.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
4.3 | 132.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
4.2 | 25.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
4.2 | 83.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
4.1 | 12.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
4.1 | 28.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
4.1 | 65.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
4.1 | 44.7 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
4.1 | 133.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
4.0 | 28.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
4.0 | 75.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
4.0 | 99.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
4.0 | 99.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
4.0 | 15.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
4.0 | 47.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
4.0 | 87.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
4.0 | 19.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
3.9 | 165.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
3.9 | 74.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
3.9 | 11.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
3.9 | 155.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
3.9 | 11.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
3.8 | 11.5 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
3.8 | 22.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
3.8 | 19.0 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
3.8 | 15.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
3.7 | 66.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
3.7 | 29.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
3.7 | 29.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
3.7 | 132.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
3.7 | 18.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
3.6 | 76.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
3.6 | 98.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
3.6 | 28.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
3.6 | 10.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
3.6 | 157.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
3.6 | 50.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
3.5 | 28.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
3.5 | 53.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
3.5 | 155.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
3.5 | 94.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
3.5 | 28.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
3.5 | 34.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
3.5 | 31.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
3.4 | 13.7 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
3.4 | 13.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
3.3 | 33.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
3.3 | 66.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
3.3 | 180.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
3.3 | 72.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
3.2 | 38.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
3.2 | 9.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
3.2 | 57.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
3.2 | 12.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
3.2 | 9.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
3.1 | 6.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
3.0 | 24.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
3.0 | 29.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
3.0 | 23.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
2.9 | 22.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.9 | 323.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
2.9 | 79.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
2.8 | 56.4 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
2.8 | 146.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
2.8 | 14.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
2.8 | 27.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
2.8 | 63.7 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
2.8 | 74.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
2.8 | 77.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
2.7 | 60.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
2.7 | 305.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
2.7 | 13.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
2.6 | 5.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
2.6 | 7.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
2.6 | 7.8 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
2.6 | 20.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
2.6 | 38.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
2.6 | 12.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
2.6 | 10.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.6 | 20.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
2.5 | 2.5 | REACTOME S PHASE | Genes involved in S Phase |
2.5 | 221.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
2.5 | 17.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
2.5 | 19.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
2.4 | 4.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
2.4 | 7.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
2.3 | 30.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
2.3 | 15.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
2.2 | 62.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
2.2 | 17.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
2.2 | 4.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
2.2 | 39.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
2.2 | 19.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.2 | 47.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
2.1 | 61.1 | REACTOME TRANSLATION | Genes involved in Translation |
2.1 | 22.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
2.1 | 30.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
2.1 | 180.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
2.1 | 4.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
2.0 | 18.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.0 | 22.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.0 | 46.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
2.0 | 10.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
2.0 | 4.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
2.0 | 82.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.9 | 11.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.9 | 1.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.9 | 11.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.8 | 1.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.8 | 42.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
1.8 | 76.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.8 | 8.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.7 | 32.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
1.7 | 8.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.7 | 45.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
1.7 | 1.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.6 | 4.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.6 | 19.3 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
1.6 | 4.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
1.6 | 1.6 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
1.5 | 23.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
1.4 | 43.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.4 | 11.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.4 | 16.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.3 | 11.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.3 | 2.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.1 | 24.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.1 | 6.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.1 | 75.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
1.0 | 3.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.0 | 4.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.0 | 1.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.0 | 1.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.0 | 2.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.0 | 11.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
1.0 | 16.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.9 | 15.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.9 | 23.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.9 | 4.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.8 | 46.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.8 | 10.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.7 | 11.0 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.7 | 2.7 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.7 | 3.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.6 | 7.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.6 | 4.5 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 10.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 51.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 9.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.2 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 3.4 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |